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One in ten adults in the U.S. report depression, and thirty-eight percent of those receiving 
treatment are receiving minimally adequate treatment.  Studies show that evidence-based 
Internet interventions are highly effective in treating depression at a low cost. The aim of 
this study was to reduce symptoms of depression in subjects through the use of a new, 
electronic Problem Solving Treatment (ePST). Adult participants with moderate to severe 
depression symptoms were randomly assigned to either treatment or a wait-list condition. 
The Beck Depression Inventory-II was used as the primary outcome measure. A 
Repeated Measure Design with one factor in the between (treatment vs control) and one 
factor in the within (pre, mid-point, and post-treatment) was used in the analysis. Study 
results showed that participants in the ePST group improved their depression symptoms 
(from Moderate to Mild levels of depression) after receiving 3 session of ePST, as well as 
after receiving six session of ePST (from moderate to minimal levels of depression). On 
the other hand, participants assigned to the control group remained with Moderate levels 
of depression. 
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CHAPTER 1: INTRODUCTION 
The World Health Organization (WHO) estimates that depression is affecting 
about 121 million people worldwide, and it is associated with the death of over 850 
thousand individuals by suicide per year worldwide (WHO, 2012). According to the 
Global Burden report, depression is the second cause of death in developing regions for 
men aged between 15 and 44. It is also projected that in 2020, depression will reach the 
2
nd
 place of the ranking of Disability-Adjusted Life Year (DALY’s)1 affecting all ages 
and both sexes (WHO, 2012). 
In the Unites States, the Center for Disease Control and Prevention (CDCP) 
estimates that one in ten adults report depression (CDCP, 2012), with an overall 
prevalence rate of 6.7% in the adult population in a 12-month period (National Institute 
of Mental Health, [n.d.]). The prevalence of Major Depressive Episode, characterized by 
symptoms such depressed mood, loss of interest or pleasure, feelings of guilt or low self-
worth, disturbed sleep or appetite, low energy, and poor concentration (WHO, 2012;  
APA-DSM-IV, 2000)varies by race/ethnicity and by age. For example, The Substance 
Abuse and Mental Health Services Administration (SAMHSA) estimated that among 
adults aged 18 or older, Asians showed the lowest (2.9%), while the rate was 12.1% 
among persons reporting two or more races, 9.2% among American Indians or Alaska 
Natives, 8.1% whites, 6.3% Hispanics, and 6.1% blacks (SAMHSA, 2008). 
                                                 
1 The Disability-adjusted life year (DALY), is a time-based measure that combines years of life lost due to 
premature mortality and years of life lost due to time lived in states of less than full health. 
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In terms of access, 51.7% of individuals in the U.S. with major depression within a 
12-month period received treatment. However, just 38% of those receiving treatment are 
receiving minimally adequate treatment (Kessler et al., 2005). Although, the numbers of 
individuals that received treatment for major depression have improved over the years 
(i.e., 51.7% in 2005 versus 71% in 2008) (National Survey on Drug Use and Health, 
2008), continuing to provide access to depression treatment to the overall population still 
remains a challenge.  
Furthermore, the health care literature demonstrates that depression detection occurs 
mainly in the primary care sector with 50% to 70% of the individuals who seek help with  
their symptoms of depression and communicate their symptoms to their primary care 
physician. Only 16% to 23% initially communicate their symptoms to a mental health 
specialist (Arnau, Meagher, Norris, & Bramson, 2001).  However, treating and 
preventing depressive disorders in the primary care sector is difficult for various reasons. 
First, the number of depressed people in the U.S. is alarming: one in ten (CDCP, 2010). 
Second, less than 50% of the depressed population receives effective treatment (WHO, 
2012; Kessler, 2005); Third, the primary care sector does not have enough specialized 
personnel to treat depressive disorders. Fourth, when it does occur, the cost of treatment 
is high. 
For these reasons a psychological intervention is necessary with the following 
characteristics: (1) evidence-based; (2) effective; (3) brief; (4) noninvasive; (5) easily 
delivered in primary care sectors; (6) administrable by non-mental health providers; (7) 
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easily learned by mental and non-mental health providers; and (8) capable of reducing 
either the direct and/or indirect economic costs. 
Problem Solving Treatment (PST) has been shown to be an effective intervention 
and fulfills the above criteria.  PST is a positive approach to clinical intervention that 
focuses on training in constructive problem-solving attitudes and skills.  The theory on 
which PST is founded involves two interrelated conceptual models: (1) the Social 
Problem-Solving (SPS) model, and (2) the Relational/Problem-Solving model of stress 
and well-being (RPS). Social problem-solving model is founded on the idea that SPS is a 
self-directed learning process, a versatile coping strategy, and a self-control method with 
important implications for the maintenance and generalization of treatment effects, and 
capable of increasing the probability of adapting coping outcomes across a wide range of 
problematic situations (D’Zurilla & Goldfried, 1971; Mahoney, 1974; Nezu, 1987).  
Further, the Relational/ Problem-Solving model of stress and well-being assumes that 
problem solving is a coping strategy that influences the relationship between stressful life 
events and well-being by functioning as a mediator. The theory further states that when 
functioning as a mediator if a problem solving coping strategy is ineffective, negative 
well-being ensues (e.g., anxiety, depression), while effective problem solving has 
positive consequences for well-being (e.g., fewer negative emotions, and more positive 
emotions) (D’Zurilla, 1990; D’Zurilla & Nezu, 1999, 2007; Nezu, 1987; Nezu & 
D’Zurilla, 1989).  
The aims then of PST are to reduce psychopathology and to enhance 
psychological and behavioral functioning.  Additionally, the treatment aims to prevent 
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relapses and the development of new clinical problems, as well as to maximize quality of 
life by helping individuals cope more effectively with stressful problems in living 
(Dobson, 2009).  
PST is a brief intervention.  The treatment lasts between four and eight sessions 
and mental health as well as non-mental health providers such as nurse practitioners, 
physician assistants, and family physicians (Gath & Catalan, 1986;  Mynors-Wallis, 
1996) can be trained to administer the intervention (Mynors-Wallis, Gath, Day, & Baker, 
2000).  In addition, the treatment can occur in primary care facilities and behavioral 
health clinics.  
Another important component is the use of telemedicine as a low-cost channel to 
disseminate evidence-based psychological interventions for depression to those who 
prefer a different treatment approach or to those that do not have access to traditional 
therapy.  Studies have shown that telemedicine is an effective tool to provide high quality 
services remotely in consultations, diagnosis and treatment to patients. Similarly, results 
have shown that combining telemedicine and psychological interventions 
(telepsychology) can reach hundreds of thousands of people worldwide and could be used 
in public sector settings to augment existing offerings and provide service not currently 
available such as prevention interventions (Muñoz, 2010). 
Over the past decade the development of Internet-based intervention studies have 
increased worldwide in order to further efforts to prevent and treat mental health 
conditions among adolescents, adults, and seniors in primary care settings. However, a 
limited number of studies have occurred in the U. S. appraising the effectiveness of this 
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approach.  To date most have been developed and conducted in Europe.  Therefore, the 
present study contributes to U.S. and international mental health literature by examining 
how well adults in the U.S. who live with depression respond to a new Internet-based 
intervention created in the U.S. and for individuals in the U.S.  
This interactive multimedia Computerized based treatment program was 
developed to provide an electronic version of problem solving therapy for depression 
(ePST)2. The program is entirely automated and does not require the involvement of a 
live clinician, although it is designed to provide a “virtual therapy” experience that feels 
more like interacting with a person than with a computer. The ePST program was built to 
help individuals who do not have access to traditional therapy due the living conditions or 
individual preferences (e.g. rural, poor and persons desiring privacy or with significant 
time constraints). Internet-based treatment of depression offers several advantages. It can 
be used anywhere without a therapist present and can offer a standardized and consistent 
approach. 
The ePST program provided a simulated therapy session based on the Problem 
Solving Treatment for Primary Care (PST-PC) treatment manual used in depression 
clinical trials (Hegel & Arean, 2003). A “virtual” therapist (who appears onscreen 
throughout the user’s engagement with ePST™ and who interacts flexibly via branching 
algorithms that provide personalized responses from the therapist to the user based on 
                                                 
2 Although ePST is a computerized-based intervention for the purposes of the present study ePST is treated 
as an Internet-Intervention since it overall goal is to be adapted and uploaded to the World Wide Web and 
since study on computerized interventions have shown similar treatment effects.   
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their input about their problem solving experiences and depressive symptoms) provided 
programmed instruction on the steps and skills of problem solving, emotional support, 
and tailored feedback to the user’s input. The ePST program required minimal reading 
skills because the therapist guided the user through the problem solving process via audio 
and video.  
In order to prove the efficacy of the ePST treating depression, a randomized clinical 
trial with a clinically depressed adult population was assigned to two treatment conditions 
(treatment and control). The current study took an important first step towards the 
creation of novel Internet-based interventions to treat depression in primary care as well 
as in remote and isolated environments. In addition, this study aimed to expand the 
current limited Internet intervention studies to treat depression available in the U.S. 
Further, this study expanded the understanding of how psychological theories, 
interventions, and technology could work together in order to provide quality access to 
those who did not have the resources. Future research will be required to replicate these 
findings, test them in isolated environments, as well as with different severity of 
depressive symptoms. 
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CHAPTER 2: LITERATURE REVIEW 
Defining Depression  
Feeling sad, tired and demoralized, as well as experiencing low self-esteem, and 
changes in sleep or eating habits are normal conditions for any human being.  However, 
when such feelings and experiences increase in frequency, intensity and duration they can 
become symptoms of an emotional or physical disorder (Muñoz, 2012). If the majority of 
the symptoms appear for the most part within a set time period, then the symptoms form 
a syndrome, such as major depressive episode (DSM-IV, APA 2000).  Finally, if the 
syndrome has a long enough duration, intensity and recurrence, it can become a disorder, 
such as major depressive disorder (MDD) (Muñoz, Beardslee, & Leykin, 2012).   
Depression is a common mental disorder that presents with depressed mood, loss of 
interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low 
energy, and poor concentration (WHO, 2012), and it is frequently associated with 
suicidal thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide 
attempt or specific plan for committing suicide  (APA, 2010-DSM-IV). Depression 
affects everyone regardless of gender, age and socio-economic status and background. 
When depression is not treated promptly and effectively, it becomes chronic or recurrent 
and could lead to substantial impairments in an individual's ability to cope, take care of 
his or her everyday responsibilities as well as interact with others (WHO, 2012). 
 
Prevalence of Depression in the U.S.  
A recent study conducted by the Centers for Disease Control and Prevention 
(CDCP) estimated that one in ten adults report depression (CDCP, 2012). This estimation 
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was determined based on responses to the Patient Health Questionnaire 8 (PHQ-8) 
(Kroenke et al., 2009)3.  In other words, about 30 million adults4 in the U.S. (US Census 
Bureau, 2012) meet the criteria for a depressive disorder according to the Diagnostic and 
Statistical Manual of Mental Disorders (CDCP, 2012).  
 Another study conducted by Kessler and colleagues estimate that 9.5% of the 
adult population presents some type of mood disorder.  Of these mood disorders major 
depressive disorder accounts for 6.7%, followed by bipolar disorder with 2.6%, and 
dysthymia disorder with 1.5% (Kessler, 2005). Among adults with major depressive 
disorder, 30.4% were classified as severe, 50.1% classify as moderate, and just 19.5 % as 
mild (Kessler, 2005). Among those with dysthymia disorder, 49.7% of the cases were 
classified as severe, 32.1% as moderate, and 18.2% as mild (Kessler, 2005). In sum, if 
major depression disorders are accounted for, there are about 600 thousand adults with 
severe symptoms of depression and about 1 million more who present moderate 
depression. In the U.S. major depressive disorder is so common that it ranks as one of the 
top five sources of premature death and disability (Michaud et al., 2006) and the leading 
cause of disability among major ethnic and racial groups and a common problem in 
medical comorbidity (González, Tarraf, Whitfield, & Vega, 2010).  
Several factors affect the prevalence of depression. A study conducted in 2010 by 
the Centers for Disease Control and Prevention reported several significant factors: sex, 
race, age, level of education, marital status, and employment status. In regards to sex, the 
                                                 
3 The PHQ-8 is measure of current depression in the general population which covers eight of the nine criteria from the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) for diagnosis of major depressive 
disorder (American Psychiatric Association) 
4  The U.S. estimated population in June 2012, is 313,570,767 
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report indicates that women were significantly more likely than men to report major 
depression (4.0% versus 2.7%) while the NIHM reported that women are 70% more 
likely than men to experience depression during their lifetime.  The Substance Abuse and 
Mental Health Services Administration (SAMHSA) estimated that among adults aged 18 
or older, past year prevalence of major depressive episode varied by race/ethnicity.  
Asians reported the lowest (2.9%), while rates were 12.1% among persons reporting two 
or more races, 9.2% among American Indians or Alaska Natives, 8.1% whites, 6.3% 
Hispanics, and 6.1% blacks (SAMHSA, 2008). In reference to age, the NIMH reports that 
in a 12 month prevalence, major depression among 18 to 25 years old is 8.7%, for those 
between 26 to 44 year olds is 7.4%, and 50 or more is 4.5% more likely (Kessler et al., 
2005). 
Regarding the level of education, individuals with less than a high school diploma 
(6.7%) and high school graduates (4.0%) were more likely to report major depression 
than those with at least some college (2.5%). In terms of marital status, depression 
prevalence among individuals that have never been married was 4.1%, while depression 
levels for married individuals was 2.2% and 6.6% to those that have divorced.  Lastly, 
individuals who are disabled (22.2%) or unemployed (9.8%) compared with homemakers 
and students (3.0%), persons employed (2.0%), and retired persons (1.6%) (CDCP, 
2010).  
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Consequences of depression 
The degree of disability produced by depressive disorders in the U.S. is high and 
affects medical costs, employment, work productivity and daily functioning at the 
individual, social, and national levels.   
a. Medical Expenses 
Depression is the leading cause of medical disability for individuals aged between 
14 and 44 (Stewart, Ricci, Chee, Hahn, & Morganstein, 2003); this selected sector of the 
population represents more than 40% of the U.S. Population5. According to the National 
Research Council (NRC) and the Institute of Medicine (IOM) 2009 report, the cost of 
depression affects much more than the mental health system it also affects the education, 
justice, and physical health care (NRC & IOM, 2009b). Moreover, research has found 
that direct and indirect cost per capita of Depression disorders is comparable to the total 
costs for other major illness like hypertension, coronary artery disease, diabetes, and back 
problems (Druss, et al., 2000 in  Johnston, Westerfield, Momin, Phillippi, & Naidoo, 
2009). 
In a study conducted with treatment-resistance depression patients (TRDP)  
findings suggested an increment of 40% in their medical care cost with an annual cost per 
patient of $1,530 higher than those with non-TRDP, while a cost per patient with 
complex TRD was of $4,425 higher than those for non-TRDP (Pincus, et al., 
2001;Gibson et al., 2010). Similarly, another study found that TRD patients had more 
severe depression and have higher medical costs for imaging tests, physician visits, 
                                                 
5 http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf. Table1 
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psychiatric hospitalizations, and number of working days lost (Fostick, Silberman, 
Beckman, Spivak, & Amital, 2010).  
Consequently, depressed patients use three times more health care services and 
seven times more the emergency room visits than individuals who are not depressed 
(Pincus, et al., 2001). It is also estimated that the total cost of depression is 2.1 trillion 
dollars for the total group over the course of their lifetimes (Smith & Smith, 2010). 
b. Employment Status 
Depression disorder affects employment and unemployment rates as well, and its 
cost burden is expressed in dollars lost due to absenteeism, disability, and presenteeism 
(i. e. being present at work but working at a reduced capacity) (Johnston et al., 2009). For 
example, studies performed by the Center for the Epidemiologic Studies Depression 
(CESD), focused on the effects of depression in employment and unemployment rates 
with adults.  Researchers found that depression was a predictor of subsequent 
unemployment and decreases in income even after controlling for baseline education, 
marital status, and history of prior unemployment (Kessler et al., 2008). Also, it was 
found that children or adults who suffer from depression have lower income, lower 
educational attainment and fewer days working each year (Smith & Smith, 2010).  
Furthermore, depressed individuals are seven times less likely to be employed (Ettner, 
Frank, and Kessler, 1997; Lerner, et al., 2004;  Kessler et al., 2008), and those who are 
employed work less hours and receive lower wages (Ettner, Frank, and Kessler, 1997; 
Kessler, Heeringa et al., 2008).  
c. Work Productivity 
 12 
In terms of work productivity, it is estimated that depressed people lose 5.6 hours 
of productivity every week when they are depressed (Stewart, 2003). A study conducted 
in a major U.S. corporation found that depressive illness was associated with a mean of 
9.86 annual sick days, significantly more than any of the other conditions (Druss et al., 
2000).  
Additionally, fifty percent of the loss of work productivity is due to absenteeism 
and short-term disability (Kessler, et al., 1999), and in any 30 day period depressed 
workers have 1.5 to 3.2 more short-term disability days (Druss, Schlesinger, & Allen, 
2001), and could lead to seven fewer weeks of work per year, which represents a loss of 
20% in potential income (Smith & Smith, 2010). It is estimated that at least 80% of 
depressed people are impaired in their daily functioning (Pratt & Brody, 2008). The cost 
of depression, including the lost productivity and increased medical expense, is $83 
billion each year, which is more than eight times the projected budget in 2012 for 
supportive education and outreach programs and for the prevention of drug abuse for 
young people and treatment services for substance abusers (Office of National Drug 
Control Policy, 2011).  
Health Care Access and Quality of Treatments for Depression  
Access and quality of care is fundamental for the prevention and treatment of 
depression in the overall population, and it is fundamental to have such services in the 
primary care system since primary care is the center of medical care (Starfield, 1998) and 
the where most mental health care is provided (Regier et al., 1993). Among mental health 
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disorders, depression can be reliably diagnosed in primary care settings ( WHO, 2012), 
and it is suggested that depression can be prevented (Muñoz et al., 2012); however, 
health care access and the quality of treatments available to treat individuals with 
depression are still limited.  These limitations include but are not limited to: access, 
shortage in providers and costly treatments. 
In terms of access, in the U.S. in a 12-month period, 51.7% of the individuals with 
major depression received treatment, however, 38% of those receiving treatment are 
receiving minimally adequate treatment (Kessler et al., 2005). Although, the numbers of 
individuals that received treatment for major depression have improved over the years 
(i.e., in 2005 the number was 51.7% and in 2008 it was 71%) (National Survey on Drug 
Use and Health, 2012) continue providing access to depression treatment to the overall 
population still remains a challenge. In addition, there is a shortage of mental health 
personnel. A recent study estimated that in the U.S., about 84 million people do not 
receive mental health care services, or they receive reduced services, because of the 
shortage of community mental health care providers (Carlson, 2010). Today, the health 
care challenge is still to provide access with high quality and at low cost rates to anyone 
who is in need of treatment for depression. 
Treatment for Depression  
Brief overview of Cognitive Behavioral Treatment 
There is vast evidence that Cognitive Behavioral Therapy (CBT) is an effective 
treatment for depression (Butler et al., 2006; Hollon et al., 2006;; Bright, Baker, & 
Neimeyer, 1999; Bruns & Nolen-Hokesema, 1991; Elkin et al., 1989; Beck, Rush Shaw, 
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& Emery, 1979) and also a prevention intervention (Muñoz et al., 2012) for depressive 
disorders. In private practice settings and in primary care settings (Høifødt, et al., 2011) 
there is an overall mild to moderate effect size across studies. The goal of CBT is to 
reduce and keep depressive symptoms below the clinical threshold; in this way potential 
clinical episodes of depression could be prevented and/or reduced (Muñoz, 2012).  
In a seminal article by Elkin and colleagues (1989) found that CBT has a 
therapeutic effect that is comparable to antidepressant medication (Elkin et al., 1989). 
Another study that reviewed 78 controlled clinical trials, with patients with major 
depression or dysthymia, proved that Cognitive Therapy was an effective intervention for 
mild to moderate levels of depression. This study also demonstrated that CBT had 
significantly better results when compared with waiting-list and antidepressants 
(Gloaguen et al, 1998). Furthermore, a recent meta-analysis conducted by Cuijpers et al., 
(2013), where a total of 115 studies compared CBT vs. control groups, showed that CBT 
is undoubtedly an effective treatment for adult depression.  Finally, it is important to note 
that the National Institute of Mental Health (NIMH) recognizes CBT as one of the most 
effective intervention to treat minor to moderate depression. 
 
Treating Depression in Primary Care Settings 
Detection of depression occurs mainly in the primary care sector with 50% to 
70% of the individuals communicating their symptoms of depression to their primary 
care physician while just 16% to 23% initially communicate their symptoms to a mental 
health specialist (Arnau et al., 2001).  As a result, over the past decade the primary care 
sector has been one of the principal settings for treating and managing depressive 
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disorders (Regier, 1988; Eisenberg 1992; Brody & Larson, 1992) in the general 
population. 
The primary care sector primarily prescribes medication to treat patients with 
depressive disorders, and in the best cases, physicians refer their patients to therapists that 
provide behavioral evidence-based interventions or interpersonal therapy (Barrett et al., 
1999). Although such services exist within the primary care sector, receiving 
psychological treament is difficult since those treatments are available only through 
referral to the specialty sector. In addition, many barriers exist to accessing mental health 
care services in the primary care sector; these include, but are not limited to, patients’ 
poor insurance coverage, distance from care facilities, time commitments, and lack of 
trained clinicans, not to mention the stigma associated with receiving psychological 
interventions (Lovell & Richards, 2000). 
 Additionally, treating depression with medication is costly and not everyone is 
amenable to taking medication. Also, not everyone benefits from psychopharmacological 
treatment (Simon et al., 1996; Kirsch et al., 2008; Hollinghurst et al., 2010). Furthermore, 
implementing CBT in the primary care sectors requires highly trained specialists and time 
commitment (12-16 sessions) (Mynors-Wallis, Gath, Lloyd-Thomas, & Tomlinson, 
1995), and this is an opportunity that most primary care settings cannot offer..   
Because older adults are more likely to seek mental health services in primary 
care medicine (Arean & Miranda, 1996), a growing number of health care settings, such 
as the Veterans Affairs (VA) system and health maintenance organizations (HMOs), are 
beginning to provide brief mental health treatment within primary care. A dilemma faced 
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by these settings is that even the briefest interventions like CBT are not designed in 
consideration of the primary care setting or with the  patient in mind, since primary care 
settings are not designed for visits longer than 30 minutes, and they do not typically 
employ staff with mental health expertise (Arean, Hegel, Vannoy, Fan, & Unuzter, 2008).  
Given these considerations, I will argue that Problem-Solving Treatment for Primary 
Care interventions (PST-PC) can address psychological problems within the parameters 
of time and resources available in most primary care settings.  
 Consequently, treating and preventing depressive disorders via the primary care 
sector is difficult given that these settings do not have enough specialized personnel to 
treat depressive disorders and given that pharmacological treatment is quite costly. In 
addition, the sheer number of depressed people and the fact that less than 25% receive 
effective treatment further underscores the complications involved in using the primary 
care sector.  As the main delivery point for interventions aimed at individuals suffering 
from depression, the primary care setting must contend with the following issues:  a) the 
number of depressed people in the U.S. is alarming: one in ten (CDCP, 2010); b) less 
than 25% of the depressed population receives effective treatment (WHO, 2012; Kessler, 
2005); c) the primary care sector does not have enough specialized personnel to treat 
depressive disorders; d) when it does, treatments are highly costly.  
For these reasons what it is needed is a psychological intervention with the 
following characteristics: (1) evidence-based; (2) effectiveness;  (3) brevity; (4) 
noninvasiveness; (5)  Easily delivered in primary care sectors; (6) administrable by non-
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mental health providers; (7)  easily learned by mental and non-mental health providers; 
(8) capable of reducing either the direct and/or indirect economic costs. 
One solution that addresses the current difficulties of treatment and prevention of 
depressive disorders in the primary care sector is Problem Solving Treatment for Primary 
Care (PST-PC) since it meets all of these requirements. 
Problem Solving Treatment Theory  
Introduced in 1970 by D’Zurilla and Goldfried (1971), PST promotes behavior 
modification, emphasizing cognitive mediation as a way to facilitate self-control and 
maximize the generalization and maintenance of behavior changes (Kendall & Hollon, 
1979). Furthermore, Problem-Solving Treatment for Primary Care (PST-PC) is a 
therapeutic intervention based on cognitive-behavioral principles (Williams, 2000).  It 
was developed by Gath at Oxford University as an alternative to medication based 
treatments for medical outpatients with depression and anxiety (Barrett et al., 1999; 
Catalan, Gath, Bond, Day, & Hall, 1991).  It is a positive approach to clinical 
intervention that focuses on training in constructive problem-solving attitudes and skills.  
The aims of PST are both to reduce psychopathology and to enhance psychological and 
behavioral functioning to prevent relapses and the development of new clinical problems, 
as well as to maximize quality of life by helping individuals cope more effectively with 
stressful problems in life (Dobson, 2009). The theory on which PST is founded involves 
two interrelated conceptual models: (1) the Social Problem-Solving Model and (2) the 
Relational/ Problem-Solving Model of Stress and Well-Being. 
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The Social Problem-Solving Model  
Social problem solving (SPS) refers to problem solving as it occurs in the natural 
social environment (D’Zurilla & Nezu, 1982). Social problem solving is a self-directed 
learning process and coping strategy and a self-control method with important 
implications for the maintenance and generalization of treatment effects (D’Zurilla & 
Goldfried, 1971; Mahoney, 1974; Nezu, 1987).  SPS is a versatile coping strategy 
capable of increasing the probability of adapting coping outcomes across a wide range of 
problematic situations. Also, SPS qualifies as a learning process because problem 
solution results in a change in performance capability in specific situations (Gagné, 
1966). Social problem solving has three major components: (1) social problem solving, 
(2) the problem, and (3) the solution.  
a) Social problem solving  
Social problem solving is a self-directed cognitive-behavioral process where an 
individual attempts to identify or find effective solutions for specific problems 
encountered in his/her everyday life (Dobson, 2009). SPS through a conscious, rational, 
effortful, and purposeful activity seeks to improve problematic situations, and/or reducing 
or modifying the negative emotions generated by these situations. As it was presented by 
Dobson (2009) SPS is more than a simple coping strategy to overcome daily situations, 
SPS is a metaprocess of understanding, appraising and adapting to stressful events.  
Therefore, SPS is capable of dealing with real-life problems such impersonal problems 
(e.g., financial problems, property damage), intrapersonal problems (e.g., cognitive, 
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emotional, behavioral, health), and interpersonal problems. (e.g., marital conflicts, 
interpersonal conflicts)  
b) The problem 
In the context of SPS a “problem” (or a problematic situation) is defined as: a) the 
imbalance or discrepancy between adaptive demands and the availability to effectively 
cope with the situation, b) any life situation or task (present or anticipated) that demands 
an effective response to achieve a goal or resolve a conflict, but no effective response is 
immediately apparent or available to the person (Dobson, 2009).   
The challenges associated with effective response to the adaptive demands may 
originate within the person, (e.g., personal goals, needs, commitment) and/or the 
environment (e.g., job demands, behavior expectations of significant others). The 
obstacles associated with these challenges depend on the problem.  A single time event 
(e.g., forgetting an important appointment) is distinguishable from a series of similar or 
related events (e.g., an ongoing pain or loneliness). Other factors that inhibit an 
individual’s capacity to improve their situation are: the complexity associated with 
situation or problem, amount of resources needed, and the any skills required.    
c) The solution 
A solution is the outcome of the problem-solving process when it is applied to a 
specific problematic situation. In addition, it is considered an effective solution if the 
situation is changed for the better.   An effective solution reduces negative emotion and 
symptoms, and on the other hand, increases positive emotions.  An effective solution 
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maximizes other positive consequences at the same time minimizes negative 
consequences.  These consequences include long-term and short-term, as well as personal 
and social outcomes.   
In summary, problem-solving therapy borrows a key principal from the social 
problem- solving model.  The adapted approach is the process to change problematic 
situations or life events for better by identifying and/or finding effective solutions to 
specific problems that demands effective response. Such changes will increase positive 
consequences and reduce negative emotions and symptoms in an individual.  
The Relational/Problem-Solving model of stress and well-being 
First, PST takes from the Relation/Problem-Solving Model (R/PSM) the 
assumptions that psychopathology symptoms can be understood and effectively 
prevented or treated if they are viewed as ineffective, maladaptive, and self-defeating 
coping behaviors that in turn have negative psychological and social consequences, such 
as anxiety, depression, low self-esteem, and impaired interpersonal functioning 
(D’Zurilla & Goldfried, 1971). Second, PST adopts from R/PSM the idea that social 
problem solving is a general and versatile coping strategy.  This coping strategy increases 
adaptive functioning and positive well-being, and as result reduces and prevents the 
negative impact of stress on well-being and adjustment (D’Zurilla, 1990; D’Zurilla & 
Nezu, 1999, 2007; Nezu, 1987; Nezu & D’Zurilla, 1989).  
In the R/PSM, stress is viewed as a function of the reciprocal relations among 
three major variables: (1) stressful life events, (2) emotional stress/well-being, and (3) 
problem-solving coping.  
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a) Stressful life events 
Stressful life events are any life experiences that present a person with demands 
for personal, social, or biological readjustment (Bloom, 1985). In this model, two major 
types of stressful life events are considered: a) a major negative event, and b) daily 
problem. Major negative events are broad life experiences that require gradual 
readjustment in a person’s life (e.g., a major illness, the lost of a love one, a job loss), 
while daily problems are viewed as narrower and specific stressful life events (e.g., see 
problem definition). Although these two types of stressful life events are independent 
from each other, they are often related. For example, a diagnosis with a chronic illness 
(major negative event) will create new stressful problems for a person such as difficulties 
paying bills, following treatment procedures as prescribed, and health problems. Equally, 
the accumulation of poor decision making, lack of healthy activities such as frequent 
exercise, getting enough sleep hours (daily problems), will cause or contribute to a 
chronic illness: a major life event.  
b) Emotional Stress (ES) 
In this model, emotional stress is a key part of a broader construct of “well-being” 
that also encompasses cognitive, behavioral, social, and physical functioning (Lazarus & 
Folkman, 1984), and it refers to the immediate emotional responses of a person to 
stressful life events, as modified, modulated, or transformed by cognitive appraisal and 
coping processes (Lazarus, 1999).  Also, emotional stress theory explains that depending 
on the nature of stressful life events, cognitive appraisals, and coping behavior, emotional 
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stress responses may be negative (e.g., anxiety, anger, depression) or positive (e.g., hope, 
relief, exhilaration, joy).   
Negative and positive emotions will be dictated by the life circumstances that 
surrounds the individual. For example, an individual will experience negative emotions 
when: 1) a stressful event is perceived as threatening or harmful to his/her well-being, 2) 
doubt exists regarding his/her ability to cope effectively, 3) coping responses are 
ineffective, maladaptive or self-defeating. In contrast, such an individual will experience 
positive emotions when 1) he/she perceives a stressful event as an opportunity for his/her 
benefit, 2) an individual believes that he/she is capable to cope effectively with the 
problem, and 3) his/her coping responses are effective, adaptive and self-enhancing 
(Dobson, 2009).  
c) Problem-solving coping 
The most important concept in the relational/problem-solving model is “problem-
solving coping,” a process that integrates all cognitive appraisal and coping activities 
within a general social problem-solving framework. A person who applies the problem-
solving coping strategy effectively (1) perceives a stressful life event as a challenge or 
“problem to be solved,” (2) believes that he or she is capable of solving the problem 
successfully, (3) carefully defines the problem and sets a realistic goal, (4) generates a 
variety of alternative “solutions” or coping options, (5) chooses the “best” or most 
effective solution, (6) implements the solution effectively, and (7) carefully observes and 
evaluates the outcome. Regardless of what goals are set, the ultimate expected outcome 
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of problem solving is to enhance adaptive coping and positive well-being, and to reduce 
the negative impact of stress on well-being and adjustment (Dobson, 2009). 
The hypothesized relationships among the major variables in the 
relational/problem-solving model of stress and well-being shows that major negative 
events and daily problems are the two types of stressful life events in the model, and that 
they are assumed to influence each other. It is important in PST to identify the daily 
problems that might be created by major negative events and to focus on solving these 
daily problems, as well as coping with the major negative event itself.   
The model assumes that problem solving influences the relationship between 
stressful life events and well-being by functioning as a mediator or a moderator. The 
model recognizes two different mediational hypotheses. The first hypothesis is based on 
the ABC model, where stressful life events (A) are assumed to set the occasion for 
problem-solving behavior (B), which, in turn results in personal and social consequences 
(C) that affect well-being. If problem solving is ineffective, negative well-being ensues 
(e.g., anxiety, depression), but effective problem solving has positive consequences for 
well-being (e.g., fewer negative emotions, more positive emotions). 
Purpose and Protocol  
PST-PC interventions aim to reduce treatment time and enhance personnel 
resources in primary care settings where patients with depression are treated. 
Furthermore, PST-PC teaches patients the close link between their everyday problems 
and their symptoms of depression and anxiety. Simultaneously, patients learn to use their 
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own skills and resources to cope with both present and future problems (Mynors-Wallis, 
1996). 
PST-PC is a brief intervention that lasts between four and eight sessions where 
mental health as well as non-mental health providers such as nurse practitioners, 
physician assistants, and family physicians (Gath & Catalan, 1986;  Mynors-Wallis, 
1996) can be trained to administer the intervention (Mynors-Wallis, Gath, Day, & Baker, 
2000) in primary care facilities and behavioral health clinics.  
As a CBT branch, PST-PC is a collaborative treatment between the therapist and 
patient in which there are three main steps: (1) the patient's symptoms are linked with 
their problems in living; (2) the problems are defined and clarified; and (3) an attempt is 
made to solve the problems in a structured way (Williams, 2000; Dowrick et al., 2000). 
Within the three main steps in PST-PC six stages are encompassed: (1) identifying and 
clarifying the problem; (2) setting clear achievable goals; (3) brain-storming to generate 
solutions; (4) selecting a preferred solution; (5) clarifying the necessary steps to 
implement the solution; and (6) evaluating progress (Mynors-Wallis et al., 1995); an 
additional stage (7) scheduling enjoyable activities is recommend (Cartreine et al., 2013).  
On subsequent sessions, participants and trained providers evaluate their success or lack 
of success at implementation, troubleshooting, and begin the cycle again. 
The CBT main components of PST are: 1) behavioral activation, 2) sense of 
control, and 3) the relationship between brain, body and behavior. Behavioral activation: 
PST activates the individual to take steps toward changing their situation rather than 
being passive.  Sense of control: PST instills a sense of control and self-efficacy, which 
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can combat feelings of learned helplessness that can cause depression. Brain-Body-
Behavior:  PST teaches a strategy of approaching life problems that can be used 
throughout the individual’s lifetime as a way of both managing and preventing 
depression. Finally, the elimination of problems in and of themselves can be of 
significant benefit, particularly for reducing stress. Although some problems may or may 
not be completely solved in treatment, the underlying idea of PST-PC is that once the 
patient starts tackling his/her problems, he/she will begin to reassert control over his/her 
lives. In other words, regaining a sense of control over life’s problems is likely an 
important factor in resolving emotional symptoms (Barrett et al., 1999). 
In summary, PST-PC’s ultimate goal is that once the technique has been learned, 
the patient will use it as a toolbox to address, prevent, cope and solve past, present and 
future problems or subsequent depression episodes. As stated, PST-PC is a brief 
treatment and ranges between four to eight individual sessions, with an approximate time 
of one hour for the first session, and 30 minutes for each subsequent session (Dowrick et 
al., 2000; Barrett et al., 1999; Williams, 2000).  
Effectiveness of PST  
PST has been tested in primary care settings to determine whether it was an 
efficient and viable intervention in community care settings in urban and rural areas. In 
community care settings when PST -PC was compared with community-based 
psychotherapy in treating late-life major depression and dysthymia, adults who received 
PST-PC had more depression-free days at 12 and between 12 and 24 months, and they 
had fewer depressive symptoms and better functioning at 12 months than those who 
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received community-based psychotherapy (Arean et al., 2008). In urban and rural areas, a 
study conducted in nine urban and rural communities in Finland, Republic of Ireland, 
Norway, Spain, and the United Kingdom, found that the proportion of problem solving 
participants depressed at six months was 17% less than that for controls, and when PST 
was offered to adults with depressive disorders in the community it was more acceptable 
than a course on prevention of depression (Dowrick et al., 2000). 
Recent meta-analyses on problem-solving therapy conducted by Cuijpers, van 
Straten et al., (2007) and Malouff, Thorsteinsson, & Schutte, (2007), found that PST was 
superior to no treatment, treatment as usual, and attention placebo for treating major 
depressive disorder. In addition, PST was demonstrated to be more effective than placebo 
and as effective as amitriptyline (an antidepressant) in treating major depression 
(Mynors-Wallis et al., 1995). Likewise, PST has proven to be an effective treatment for 
major depression (Mynors-Wallis, 2002; Mynors-Wallis, Gath, Lloyd-Thomas, & 
Tomlinson, 1995; Oxman, Hegel, Hull, & Dietrich, 2008) and minor depression 
(D’Zurilla & Nezu, 1999) in primary care. 
Furthermore, PST was found to be an effective treatment for older adults 
(Alexopoulos, Raue, & Areán, 2003) ; Charney et al.,2003; Kendrick et al., 2005; 
Mynors-Wallis et al., 2000), and as effective as an antidepressant medication in treating 
major depression in younger patients (Mynors-Wallis et al., 1995; Mynors-Wallis, Gath, 
Day, & Baker, 2000) in primary care settings. Additionally, in a study that examined if 
PST could be administered by research general practitioners or research practice nurses to 
treat depressive disorders, researchers found that PST was an effective treatment for 
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depressive disorders in primary care, and most importantly, PST could be delivered by 
suitably trained practice nurses or general practitioners (Mynors-Wallis et al., 2000).  
Similar findings were obtained by Unutzer et al., (2002) where nurse practitioners with 
no prior mental health treatment experience were able to deliver this brief intervention in 
a reliable fashion. 
Application of Computerized PST  
Because PST is highly structured and modular, brief, has good “common sense” 
face validity, low attrition rate, and can be delivered by non-mental health providers or 
specialists, it is uniquely suited for adaptation to computerized delivery. The National 
Space Biomedical Research Institute (NSBRI) and the National Aeronautics and Space 
Administration (NASA) are attempting to take this next step by moving PST-PC from a 
provider-administered treatment to a self-administered one. If successful, it will enable 
this brief but effective intervention to be delivered at any location at any time via 
computer—including rural areas, isolated communities and even in outer space (Cartreine 
et al., in press).   
Telemedicine & Telepsychology  
Telemedicine 
Telemedicine (from its Greek roots ‘tele’, meaning far or distance, and medicine), 
refers, in general terms, to the ability to provide medical care at a distance. The primary 
objective of telemedicine is to provide high quality medicine and care without the 
physical presence of the provider, and the overall assumption is that telemedicine will 
address particular unfulfilled necessities that a nation’s health care system has in terms of 
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its medical services (Ferrer-Roca, 1998). Telemedicine can help medical centers that lack 
or have limited infrastructure, limited resources or are geographically isolated, by 
connecting them to centers that have highly trained on-site personnel in order to provide 
health services through long-distance communication (Heinzelmann et al., 2005; Zundel, 
1996). Telemedicine can also reduce times of consultation, diagnosis and treatments 
while reducing the need for clinical visits (Fong, Fong, & Li, 2010). It facilitates the 
exchange of medical data between, and within, health care systems. Moreover, 
telemedicine reduces medical disparities when there is a lack of specialized personnel 
across health care systems. Finally, telemedicine improves health care access and can 
bridge the gap between patients and providers regarding social and cultural barriers 
(Currell et al., 2000; Craig et al., 2005; Heinzelmann et al., 2005; Muñoz, Cuijpers, Smit, 
Barrera, & Leykin, 2010).  
Telemedicine can be as simple as two doctors talking about a patient through the 
telephone or internet, or as complex as a sophisticated global hospital enterprise network 
that supports real-time remote surgical operations with surgeons simultaneously situated 
in different parts of the world controlling an operation that takes place in one hospital 
(Fong et al., 2010). 
Telemedicine has been used in hospital, clinics, communities, and satellite health care 
units in urban and rural areas since the 1960’s. One of the earliest documented uses of 
telemedicine was in 1967 between the Boston Logan Airport and the Massachusetts 
General Hospital where a black and white image microwave link was established for 
emergency services at the airport (Dwyer 1973; Ferrer-Roca, 1998). In 1970, the Miami 
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School of Medicine delivered telemedicine (medical appointments) for prisoners, 
demonstrating to be successful in 70% of cases, and it was cost effective as well 
(Sassmore & Sander, 1978).   
Focus on Rural areas  
Between the 1960’s and 1970’s the federal government funded the project 
INTERACT based at the Dartmouth Medical School. This project, developed in mostly 
rural areas, consisted of supporting and implementing seven telemedicine research and 
demonstration projects6 nationwide where medical staffing had been a critical issue 
(Zundel, 1996). Another project using telemedicine in rural areas was in 1989 by the 
Texas Tech Health Science University through the MedNet project that provided support 
to 37 rural communities (Ferrer-Roca, 1998).   By the late 1980’s the North-West 
Telemedicine Project demonstrated that the introduction of new communication facilities 
could improve the quality of health care for persons living in isolated areas or 
environments (Watson, 1989). In 1994, Oklahoma Telemedicine Network provided 
diagnostic services to 38 rural hospitals (Ferrer-Roca, 1998). Twenty years after the first 
pioneer project of telemedicine, the American Telemedicine Association (ATA) was 
established in 1992 offering services such as: support to patients under dialysis, distant 
consultation in dermatology, neurology, pediatrics, oncology, psychiatry, various forms 
of diagnosis or care at a distance on neuroradiology, cardiology, gastroenterology, 
orthopedics, and speech treatment (Ferrer-Roca, 1998).   
                                                 
6 The seven projects happened in:  1) New Hampshire, 2) Maine; 3) Puerto Rico; 4) Minnesota; 5) Alaska 
6) Washington, and 7) Arizona. 
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Clinical Care Applications: Telepsychiatry and Telepsychology  
In the 1970s a study that used a two-way television network, found that 
telepsychiatry was an effective way to support non-psychiatric physicians in helping 
them improve their knowledge of psychiatry and treat emotionally ill patients, and most 
importantly, it was not a significant barrier to the establishment of rapport between 
doctors and patients or to the perception of emotional nuances, with patients reporting 
high acceptance (Zundel, 1996). Telepsychiatry was also tested with paranoid patients, 
and the circumstances of the interviews did not seem to foster additional anxiety, nor did 
the television system become the object of psychotic elaboration (Solow et al., 1971).  
Further testing on telepsychiatry has been conducted in community centers to 
treat behavioral problems, anxiety, PTSD and sexual abuse. For example, Rusking et al., 
(2004) in a randomized clinical trial that compared telepsychiatry with in-person 
treatment services with depressed veterans using psychotropic medication, psycho-
education, and brief supportive counseling for 6 months in an outpatient clinic, found that 
remote treatments of depression have comparable outcomes and equivalent levels of 
patient adherence, patient satisfaction, and health care cost when compared to in-person 
interventions. Yuen et al., (2010) used telepsychology through Skype videoconferencing- 
a type of Internet intervention, to treat social anxiety disorder where patients were able to 
engage exposure during sessions by practicing social situations (e.g., initiating 
conversations with strangers, group conversations at a party, public speeches) and 
performed role plays seated in front of a Webcam in the same room as the therapist.  The 
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study reported that patients’ anxiety increased when first engaging in the exercise but 
then they got habituated to the exposures.  
If telemedicine solutions are wisely introduced into everyday practice, in the 
broad spectrum in the health care settings and system then the “tele” will be dropped, as 
will simply become an integral part of medicine.  
Internet-Based Interventions 
In a meta-analysis of 92 empirical articles, Barak et al., (2008) examined the 
effectiveness of Internet-based psychological interventions, including different forms of 
delivery.  The study revealed that Internet-based psychological interventions have an 
overall effect size of d= 0.53 (large effect size) which is similar to the average effect size 
of traditional face-to-face therapy. It was also found that depression interventions had an 
overall effect size of d=0.32 (medium effect size). Moreover, interventions based on CBT 
models had an effect size of d=0.83, while psycho-education interventions had an effect 
size of d=0.46.  Meta-analysis concluded that Internet-based psychological interventions 
were more effective with patients between ages of 25-39 with an effect size of d=0.69, 
followed by ages between 19 -24 with a d= 0.48.   
 Another meta-analysis conducted by Anson and Cuijpers (2009) about the effects 
of studies treating depression using computerized psychological interventions with 
control groups (care as usual, wait list) showed main effects between Internet-based and 
other computerized psychological treatments vs. control groups at posttest of d=0.41; 
however, effects sizes were significant greater for those studies that had support (e.g., 
therapist involved, automated, telephone, email) with a d=.61, as compared to treatments 
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that were unsupported (d=0.25).  These results are consistent with Newman et al., (2011) 
and Titov’s (2011) meta-analyses.  
Another meta-analysis that examined the efficacy of internet-delivered 
intervention with a CBT or a PST model in treating adult patients diagnosed and/or with 
elevated symptoms of depression confirmed that both interventions were effective (Titov, 
2011); however, guided internet-delivered psychotherapy interventions were superior to 
those that were self-guided programs.  
Another study conducted by Reynolds et al., (2011) about possible resources that 
can be used in primary care facilities and by general practitioners for anxiety and 
depression, argued that online interventions can benefit both the general practitioner and 
the client. For example, the client will receive appropriate evidence-based mental health 
interventions and the time to receive treatment will be shorter. From the point of view of 
the general practitioner, online interventions can be used as adjunct to their traditional 
interventions, and they will be more involved in the mental health process. Reynolds 
presented a list of seven websites providing information about anxiety and/or depression 
and nine other based-interactive Internet programs for anxiety and/or depression. 
At this time there is significant scientific evidence supporting the effectiveness of 
Internet and/or computer-delivered psychotherapy interventions (Kaltenthaler et al., 
2006; Kaltenthaler et al., 2008; Marks et al., 2007; Marks and Cavanagh, 2009; Spek et 
al., 2007) used as treatment for anxiety and depression symptoms in primary care 
settings. Evidence indicates that Internet interventions can be used as adjunctive 
interventions and/or as standalone treatment.  Finally, Internet interventions are effective 
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enough in reducing health disparities that the National Institute for Health and Clinical 
Excellence in the UK has approved such treatment as a viable possibility in primary care. 
How it is used 
Over the past decade studies and development of Internet interventions have 
increased worldwide in order to fill the gaps in our efforts at preventing and treating 
physical and mental health conditions with adolescents, adults and seniors in primary 
care settings. In addition to depression studies, research about the use of Internet 
interventions for mental health conditions included but are not limited to:  Anxiety 
(White et al., 2000; Hayward et al., 2007; Shneider et al., 2005; Craske et al., 2009); 
OCD (Mouton-Odum et al., 2006; Greist et al., 2002); PTSD, (Hirai & Clum, 2005; 
Lange et al., 2003; Zucker et al., 2009).  
The efficacy of Internet-based interventions for depression  
Since the early 2000s there has been a scientific push to demonstrate the 
effectiveness of Internet-based interventions for depression (Warmerdam et al., 2010). 
However, most of the clinical trials to date have been conducted in European countries.  
For example, in 2003, in a randomized clinical trial in England with depressed and 
anxious adults, participants were assigned to either a treatment by an interactive 
multimedia program based on cognitive behavioral techniques, [beating the blues 
tm  
 
(BtB) program,] or to a General Practitioner Treatment as Usual (TAU) in primary care. 
Results showed that patients who received BtB had significant improvement in 
depression and anxiety compared with TAU by the end of treatment at 2 and 6 months 
follow-up. It was demonstrated that BtB by itself, and under minimal clinical supervision, 
brought rapid clinical and statistically significant improvement, decreasing symptoms of 
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depression and anxiety as well as in work and social adjustment relative to TAU 
(Proudfoot et al., 2003).  Another randomized control trial was conducted in England for 
depressed adults placed participants at a website offering information about depression 
(BluePages) or a CBT therapy website (MoodyGYM) or a control intervention using an 
attention placebo (weekly contact with a lay interviewer to discuss lifestyle factors such 
as exercise, education and health habits) group. Results indicated that both CBT and 
psycho-education delivered via the Internet were effective in reducing symptoms of 
depression compared with a credible control intervention in reducing symptoms of 
depression in a community sample with an overall effect size of d=0.30 (Christensen et 
al., 2004).  
Similarly, in 2005, Andersson and colleagues conducted an RCT in England with 
people with mild to moderate depression and were allocated to either treatment (Internet-
delivered psychotherapy based on CBT model) or waitlist. Consistent with previous 
studies, results showed that the treatment group experienced greater reduction of 
depressive and anxiety symptoms, with a between-group effect size at post-treatment on 
the BDI-II of .94 (Andersson et al., 2005). In another RCT conducted in Europe, 
participants with elevated symptoms of depression were assigned to either the six version 
of the MoodGym program or to a control group found that the treatment group had a 
significant improvement with a within-group effect size of the Goldberg Depression 
Scale ranged from .20 to .40 (Christensen et al., 2006).  
Perini et al., 2009 RCT’s study with Australians and New Zealanders participants 
that met the criteria for major depression according to the DSM-IV were assigned to 
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either treatment using an Internet-intervention based on a CBT model or a waitlist control 
group.  Results indicated that the treatment group had a large reduction in depressive 
symptoms, with a between-group effect size at post-treatment on the BDI of 0.89. 
 Furthermore, when Warmerdam and colleagues examined in a RCT in the 
Netherlands the utility and cost-effectiveness of Internet-based cognitive behavioral 
therapy (IBCBT), Internet-based problem solving treatment (IBPST), and waiting list 
with clinically significant depressive symptoms, study outcomes showed that IBCBT and 
IBPST were superior compared with waiting list control group in reducing symptoms of 
depression and enhancing quality of life after week 12 (data was collected at baseline and 
5, 8 and 12 weeks follow-up) (Warmerdam et al., 2008). From a cost-effective point of 
view, IBCBT and IBPST showed a 91% and 89% probability respectively of being more 
cost-effective in the general population, even when the society had a limited willingness 
to pay for a reliably improved patient (Warmerdam et al., 2010). 
Other European studies that used Internet-interventions that have been effective 
include: Van Voohees et al., (2009), Alvarez, Sotres, Leon, Estrella, & Sosa (2008), and 
Wright et al., (2005). The first study demonstrated that when CBT Internet Intervention 
was added to a 5 to 10 minute physician directed motivational interview, plus 3 
motivational phone calls, it was superior to 1-2 minutes of physician’s advice (Van 
Voohees et al., 2009).  The second study showed that when university students used a 
therapy assisted computer program in conjunction with researcher assistance, results 
indicated improvement in cognitive impairment, academic performances and depressive 
symptoms, whereas antidepressants only improved depressive symptoms (Alvarez, 
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Sotres, Leon, Estrella, & Sosa, 2008). Finally, the last study compared a 250 minute lab-
based computer program with 450 minutes with therapist-delivered therapy and results 
indicated no significant difference between the interventions (Wright et la., 2005). In a 
new RCT for depressed adolescents and young adults or higher health service utilizers in 
the United States, subjects were assigned to a pure Internet-based CBT interactive self-
help program plus treatment as usual (TAU) or to TAU plus access to a health 
management organization (HMO) website with statistical information about depression. 
The results showed a between-group treatment effect size on the Patient Health 
Questionnaire-8 Item (PHQ-8) at 32 weeks of .020, with a moderate effect size among 
women of 0.42 (Clarke et al., 2009).    
Contrary to previous studies, De Graaf et al., (2009) in a clinical randomized trial 
that compared Computerized Cognitive Behavioral Therapy (CCBT) using the “Colour 
Your Life program” without support, Treatment as Usual (TAU) by a general practitioner 
(GP); or online, and unsupported CCBT plus GP combined, results suggested that 
although all three groups improved in their depression symptoms substantially at 6 
months follow-up (within group effect size = 0.86, 0.81 and 0.89 respectively), CCBT 
did not outperform usual care by itself and the combination of both did not have 
additional effects. De Graff also suggested that CCBT without any support is not 
beneficial for all people with depression; however, the use of CCBT plus therapist 
support could be beneficial as a secondary treatment. In a follow-up critique of De 
Graff’s study, it was hypothesized that factors that contributed to CCBT not being 
effective in treating depression was that participants were recruited from a normal 
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community sample and many of them might not ever have sought treatment (Andrews, 
2010).  
In summary, for more than a decade, scientific curiosity for adapting 
psychological theories (e.g., cognitive behavioral therapies) with computer software 
and/or web designs has resulted in new ways to treat individuals with mental health 
disorders and behavioral problems. Internet-based interventions, since their development, 
have been tested through randomized clinical trials mainly in Europe, Australia, New 
Zealand and the Netherlands, and these studies have demonstrated their effectiveness for 
treating symptoms of mental disorders.  
Although these Internet interventions for depression are effective (e.g., 
MoodGym, and Beating the Blues), most of them are text oriented, contain minimal 
audio and video, and the intervention is guided by cartoons and/or by animations.  In 
comparison, ePST is unique.  This approach to Internet intervention is more dynamic 
(i.e., the intervention is heavy in audio and video, and is less text oriented).  Moreover, 
this approach enhances accessibility, even to those who are not highly literate.  
Currently there is a gap in the literature with respect to Internet interventions for 
depression.  As mentioned, the effectiveness of Internet-based interventions have been 
conducted, though they are few in number.  Furthermore, very few studies have assessed 
the effectiveness of this approach on populations in the U. S.  Moreover, no study has 
been performed to determine the effectiveness of the ePST intervention for depression on 
a population in the U.S.  Accordingly, the present study aims to fill the gap in the 
literature.  
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PROPOSED STUDY 
Interventions and proof-of-concept studies have demonstrated that evidence-based 
Internet interventions can reach hundreds of thousands of people worldwide and could be 
used in public sector settings to augment existing offerings and provide service not 
currently available such as prevention interventions (Muñoz, 2010). 
An interactive multimedia computer-based treatment program was developed to 
provide an electronic version of problem solving therapy for depression (ePST). The 
program was entirely automated and did not require the involvement of a live clinician, 
even though it was designed to provide a “virtual therapy” experience that feels more like 
interacting with a person than with a computer. The ePST program was built to help 
individuals who did not have access to traditional therapy due the living conditions or 
individual preferences (e.g. rural, poor and persons desiring privacy or with significant 
time constraints). This computer-based treatment of depression offered several 
advantages. It can be used anywhere without a therapist present, and offered a 
standardized and consistent therapeutic approach. 
The ePST program provided a simulated therapy session based on the PST-PC 
treatment manual used in depression clinical trials (Hegel & Arean, 2003). A “virtual” 
therapist (presented via audio and video) provided programmed instruction on the steps 
and skills of problem solving, emotional support, and tailored feedback to the user’s 
input. The ePST program required minimal reading skill because the therapist guided the 
user through the problem solving process via audio and video. Below are the three 
primary research questions and a sub-question of this study: 
 39 
Research Questions:  
1. Does ePST improve depression when compared to a wait list control group at 
mid-point and post-test treatment?    
2. Are there significant changes in the ePST group and in the control group across 
the three assessment times? 
3.  Is there a treatment interaction between Groups and the times assessments?  
As a supplementary analysis the following question was examine: 
4. Is ePST a user-friendly software for the treatment of depression? 
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CHAPTER 3: METHODS 
Hypotheses 
The following null hypotheses were tested: 1) There was no differences in 
depression level between groups at pre, mid-point and post-test treatment; 2) there was no 
differences in depression levels across testing occasions (mid-point treatment and post-
test) for both treatment and control group. 3) There was not interaction effect between 
group and times. 
Research Design  
This research employed a two factor [Ax(B)] mixed method factorial 
experimental design with one between subject factor (ePST vs Delay Entry Control)  and 
one within subject factor:  Time ( pre, mid-point, and post treatment). The between factor 
has two levels and the within factor has three levels.   
Recruitment  
Participants were recruited through announcements in the local media, university 
health centers, hospitals, churches, workplaces, and community center bulletins in the 
greater Boston area.  The Beth Israel Deaconess Medical Center IRB’s Committee as 
well as The University of Texas-Austin IRB’s Committee approved the study protocols. 
There were no adverse events for any participants.  
Screening 
Participants over 18 years of age, who reported interest in the clinical trial and 
were eligible, were contacted by the Principal Investigator to do a pre-screening 
interview over the phone. The purpose of this pre-screening process was to explain the 
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study to potential participants and to pre-screen them. This screening interview contained 
three components: 1) Brief description of the study, 2) Inclusion criteria, and 3) 
Exclusion criteria. 
Pre-screening phone interview 
Brief description of the study:  In this phase, the PI contacted potential participants who 
had indicated interest and asked them whether they were interested in participating in a 
study that was examining the use of a computerized psychological intervention to treat 
adults who present symptoms of depression. Only potential participants who verbally 
consented to be screened, were asked questions regarding the pre-screening to see if they 
met inclusion criteria.  
Pre-screening inclusion criteria: In this component potential participants were asked 
demographic questions (e.g., age, gender, ethnicity, educational level, and computer 
usage). Furthermore, potential participants were asked for their current use of 
psychological services and/ or psychiatric medications (See full description of the 
inclusion criteria in Section page. 50). Additionally, potential participants were screened 
for depression using the Patient Health Questionnaire-9 (PHQ-9), and for current use of 
psychological services and/or psychiatric medications (See full description of the 
inclusion criteria in Section C and the Inclusion Criteria Questionnaire in Appendix 3). 
During this phase, questions regarding possible suicidal ideation, plans or attempts or 
thoughts about hurting themselves (i.e., Item 9 “Thoughts that you would be better off 
dead, or of hurting yourself” in the PHQ-9), were omitted, by recommendation of the 
IRB Committee. These questions however, were asked during the In-Person Intake 
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Session (see below), in order to guarantee the safety of the participants, and to provide 
them, if that was the case, with local referral numbers so they can contact other services 
in the area.  
Pre-screening exclusion criteria: In this component potential participants were asked 
questions – to the best of their knowledge, about current and/or previous diagnoses of 
medical and psychological conditions, and about their current use of antidepressant 
and/or antipsychotic medications. (See full description of the Exclusion criteria in Section 
C and the Exclusion Criteria Questionnaire in Appendix 2). 
If potential participants did not meet any pre-screening exclusion criteria and did 
meet the inclusion criteria, and if they consented verbally and indicated interest in 
participating in the study, they were then invited by the PI to the Beth Israel Deaconess 
Medical Center- Clinical Research Center (BIDMC-CRC) facilities for an In-Person 
Intake Session. Potential participants who reported having met any of the exclusion 
criteria were not eligible to participate in the study, and they were informed that the 
present study was not suitable for them at this time. The study coordinator provided them 
with some local referral numbers so they can contact other services in the area (See script 
in the Appendix 5, Script 2a). No other data, including the participant’s history, was 
collected at this time. The description of participants screened out and excluded are show 
in Figure 1. 
Week 0: In-Person Screening 
The goals of the intake session were: A) To enroll potential participants who met 
enrollment criteria and who agreed to participate in the study by signing the informed 
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consent form; and B) To measure his or her baseline level of depression. The intake 
session was conducted in person by the PI with the potential participant in a designated 
private room at the BIDMC-CRC facilities.  
The Intake Session was conducted face-to-face at the CRC. It was divided into 7 
parts:  
1) Explanation and description of study 
2) Sign informed consent form  
3) Evaluation regarding inclusion criteria 
4) Evaluation regarding exclusion criteria 
5) Administration of baseline assessment 
6) Random assignment to group 
7) Scheduling of participants 
The informed consent process as well the ePST treatment sessions took place in a 
designated room on the BIDMC-CRC. 
Explanation and description of the study: During this phase, the PI gave a detailed 
description of the study to potential participants in a private room at the CRC facilities. 
During this time participants had the opportunity to ask questions about the study, as well 
as about the study’s benefits and risks. Once the potential participant agreed to be part of 
this screening he/she continued with the second component of this phase: Sign informed 
consent form. 
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Sign informed consent form:  The PI explained in detail the informed consent form to the 
participants. Only participants who signed the consent form continued with the 
administration of the baseline assessment. 
 
Evaluation regarding inclusion criteria: In this component subjects were asked questions 
about the inclusion criteria (Appendix 3). A trained psychology student administered the 
PHQ-9, a psychometrically validated screening instrument for clinical depression. In 
order to meet the inclusion criteria, participants needed a score between 10 to 20 on the 
PHQ-9, which indicates a Moderate to Moderately severe Depression level. At this time, 
participants were asked suicidality questions. It was part of the study protocol, that in the 
event that participants indicated a score of 1, 2, or 3 on item 9 on the PHQ-9, the trained 
psychology student would implement the safety protocol (See Appendix 5).  
 
Evaluation regarding exclusionary criteria: Once the participant met the inclusion 
criteria, he/she was asked questions based on the exclusion criteria questionnaire (see 
Appendix 2).  In addition to the questionnaire, the use of the Mini International 
Neuropsychiatric Interview (MINI) helped to make diagnoses and identified potential 
subjects who did not meet the study criteria.  The MINI is a brief, structured diagnostic 
interview that assists in the diagnosis of psychiatric disorders, based on DSM-IV and 
ICD-10 criteria (Sheehan et al., 2009). In the current study, depressed mood was assessed 
via self-report (PHQ-9, BDI-II and Hopkins) and confirmed by a clinical interview 
conducted by a trained clinician. 
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Administration of baseline assessment:  The baseline dataset was based on the 
demographic protocol (see Appendix 1), and the depression questionnaire (BDI-II, PHQ-
9, and The Hopkins Symptom Check List-20-d). Once participants completed the 
measures, they continued with the last step of the In-Person Intake Session: random 
assignment to group.  
 
Random assignment to group: Participants were informed that they were being randomly 
assigned to one of the two possible groups: Electronic Problem Solving Treatment 
(ePST) or Delayed Entry Control group (DEC). The PI gave an envelope to participants 
that contained a randomly assigned unique number and a randomly selected study group 
(ePST or DEC). A computerized random number generator determined randomization. 
The use of block randomization was used to ensure equal number of subjects in each. 
Scheduling of participants: Participants in the ePST were scheduled to use the software, 
while DEC participants were scheduled for a 4-week follow-up.  
Study Criteria  
Inclusion criteria 
In order to be part of the study, potential participants had to meet the following 
criteria:  
1. Be 18 years of age or older.  
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2. Present symptoms from the following criteria based on the DSM-IV-TR: Major 
Depressive Episode, Mood Disorder Due to a General Medical Condition and/or 
Adjustment Disorder with Depressed Mood.   
3. Depression must be the primary diagnosis and not occur secondary to any other 
diagnosis such as PTSD, anxiety disorders, social phobia, or complicated 
bereavement. 
4. Not receiving psychological treatment (e.g., face to face) at the time of the study.  
5. Not currently receiving Problem Solving Treatment in any other context. 
6. Not reporting/reported suicidal attempts in the year prior to their participation in 
the study. 
7. Be able to write and speak English according to Rapid Estimate of Adult Literacy 
in Medicine (REALM) test scores.  
Potential participants who were taking anti-depressants were included, but were 
questioned about changes in medication or in dosage at the start of each scheduled 
appointment. Subjects who reported discontinuing psychiatric medications on their own, 
changing dosages on their own or who otherwise showed clinical instability or worsening 
symptoms were referred to medical backup for evaluation, in accordance with safety 
protocols (see Appendices 6and 7);  
Exclusion criteria 
Potential participants were excluded from the study for any of the following 
reasons:  
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1. Current suicidal ideation, history of suicidal attempts or self-injurious behavior at 
any point during the protocol. 
2. Have been diagnosed with schizophrenia, bipolar I disorder, with psychosis, other 
disorder with psychotic symptoms, and/or brain injuries that includes loss of 
consciousness > 15 minutes and /or posttraumatic amnesia of any duration.  
3. Any history of treatment with antipsychotic medication. 
4. A felony conviction. 
5. Any current or recent (i.e. within the previous 6 months) substance 
abuse/dependence diagnosis (other than nicotine or caffeine). 
6. Undergoing current psychological treatment (e.g., face to face). 
Participants who indicated suicidality or self-injurious behavior during the 
screening process were assessed by medical staff and if needed, they were referred for 
services. Other participants who indicated having been diagnosed with schizophrenia, 
bipolar disorders, or presented with psychotic symptom (e.g., hallucinations), and/or 
brain injuries as well as presenting with current substance abuse/dependence (other than 
nicotine or caffeine) and/or were currently undergoing to psychological treatments (e.g. 
face to face) were excluded from the study. No participant was excluded based on gender, 
race, ethnicity, and sexual orientation.  
 
The optimal time for completion of the study is illustrated in Table 1, see below. 
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Table 1. Optimal time for completion of the trial  
Optimal time for completion 
 Pre-
Screening 
Week 0 Week 
1 
Week 
2 
Week 
3 
Week 4 Week 
5 
Week 
6 
Week 7 
 
ePST 
 
--------- 
Intake/ 
Baseline 
Session 
1 
Session 
2 
Session 
3 
Mid-Point 
assessment 
and 
Session  
4 
Session 
5 
Session  
6 
 
Post-
Treatment 
evaluation 
 
 
 
DEC 
 
 
 
--------- 
 
 
Intake/ 
Baseline ---------------------------- 
 
 
Mid-point 
assessment ----------------- 
Post-
Treatment 
evaluation 
and  
beginning 
of ePST if 
desired 
 
1. Procedures 
Once participants were screened and randomized, they were assigned to their 
groups (N=45). Those in the intervention condition –ePST group, (ePST=56) received the 
computerized intervention via flashdrive and they were able to use it in the designated 
room at the CRC. Participants who had been randomized into the ePST were asked to do 
six ePST sessions. The first session occurred within one week of enrollment, and most of 
the following sessions were scheduled at the outset as close to a weekly basis as possible. 
Participants in the DEC group (DEC= 20) were scheduled to come for a mid-point 
assessment (4 weeks after baseline) and for a post-treatment assessment point (7 week 
after baseline).  Both treatment groups were equally economically compensated for every 
time they filled out the clinical measures.   
 
2. Intervention 
Electronic Problem Solving Treatment (ePST) 
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ePST is an interactive multimedia computer-based treatment program that was 
developed to provide an electronic version of problem solving therapy for depression 
(ePST). The program is entirely automated and does not require the involvement of a live 
clinician, although it is designed to provide a “virtual therapy” experience that feels more 
like interacting with a person than with a computer. The ePST program was created to 
help individuals who do not have access to traditional therapy due to particular living 
conditions (e.g. rural, poor, or with significant time constraints) or individual preferences 
(e.g. persons desiring privacy). Also this computer-based treatment of depression was 
developed to offer several advantages: it can be used anywhere and following the 
person’s own schedule, effective treatment without needing a live therapist, and increases 
the number of evidence-based interventions, and addresses the lack of mental health 
providers nationwide).  
The ePST program provides a simulated therapy session based on the PST-PC 
treatment manual used in depression clinical trials (Hegel & Arean, 2003). A “virtual” 
therapist (presented via audio and video) provides programmed instructions on the steps 
and skills of problem solving, emotional support, and tailored feedback to the user’s 
input. The ePST program requires minimal reading skills because the therapist guides the 
user through the problem solving process via audio and video (Cartreine et al., in press). 
The first session is comprised of seven components: 1) A welcome to the ePST by 
the virtual psychologist; 2) Depression self- assessment of current depression symptoms; 
3) Psycho-education about depression; 4) Introduction to Problem Solving Treatment 
(PST); 5) Explanation and exercise of the PST components (i.e., stating a problem, 
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stating a goal, brainstorming, choosing solutions, creating an action plan and scheduling 
enjoyable activities). At the end of the session, a print out of the treatment plan is 
generated.  
Subsequent sessions (sessions 2 to 6) include: 1) a welcome to the current session; 
2) Depression self-assessment of current depression symptoms using an in-built PHQ-9; 
3) Comparison between previous and current depression symptoms; 4) Check of the 
status on how the problem solving unfolded and the level of participant satisfaction; 5) 
Troubleshoot the action plan; 6) Suggestions for improvement; 7) Development of an 
action plan; 8) Evaluation of the action plan; 9) Option to work on other problems or not; 
10) Schedule enjoyable activities; and 11) Read about PST cases.  
As a security measure for this clinical trial, the ePST software created a printed 
evaluation report of patient’s depressive symptoms. The report showed whether the 
participant expressed any suicidal intent or ideation or increment in their depression 
symptoms. The PI or Research Nurse verified the reports and then decided whether or not 
the participants were at risk. A second print out was automatically generated, for the 
convenience of the participant, at the end of the session. This report included the 
objectives, the goal, the step-by-step treatment plan, and the list of the enjoyable 
activities planned for the week. Only the participant had access to this print out.  
 
Delay Entry Control (DEC) Group  
Participants in the waitlist group were asked to attend the intake session, and 
came from a Mid-point depression assessment four weeks after baseline and for a final 
depression assessment session at week seven. The PI or CRC staff called participants two 
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days before their assessment time session to schedule the appointment. The same logistic 
procedures were applied between Mid-point assessment and Post-treatment session. 
Assessment time points 
To monitor participants’ depression levels, clinical deterioration, and other 
clinical concerns as well as their progress, the intervention set up three time assessments 
points: 1) Baseline (week 0), 2) Mid-point assessment point (week 4), and 3) Post-
Treatment assessment point (week 7). 
Baseline (week 0) 
During the In-Person Intake Session (at Week 0), and prior participant 
randomization, participants were asked to complete a series of self-assessment measures. 
These assessments, administered by the PI, served to set participants’ baseline. 
Mid-point assessment (week 4) 
          Participants in both group conditions were contacted by the PI or by one of the 
CRC staff via email and/or phone to return for the completion of the Mid-point 
assessment. DEC participants were assessed 4 weeks after baseline assessment, while 
ePST participants were assessed before starting session 4 of the ePST. Mid-point 
measures were identical to baseline measures.  
Post-Treatment (week 7) 
Post-treatment measures were identical to baseline and mid-point assessments, 
with the addition of an adherence scale for those in the ePST group. This scale was the 
System Usability Scale (in-built in the ePST software).  After completing these 
assessments, only ePST participants were invited to participate in a 30-minute debriefing 
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session. This procedure was voluntary and optional for them. The goal of the debriefing 
session was to find out what the participants liked or disliked about the ePST and 
suggestions for improvement. Data collected from the debriefing session was analyzed 
qualitatively and compared to their responses on the System Usability Scale (SUS). 
Safety Measures and Protocols for Participants with Suicidal Ideation or Other 
Symptoms of Clinical Deterioration  
There were several ways in which the PI identified and responded to suicidal 
ideation or other forms of clinical deterioration. They included:  
1. Screening and Selection 
2. Monitoring of Depression and Risk of Suicide Protocol  
3. Procedural Manual for Safety – Clinical Coverage 
4. Monitoring for Clinical Deterioration  
5. Monitoring Risk for Suicide Protocol 
6. Informed Consent Process 
Screening and Selection 
The present study had set up multiple measures in order to ensure the safety of its 
participants. The first safety measure was reflected in the study’s inclusion and exclusion 
criteria (see Section C-Subjects selection). The rigor of these criteria reduced the 
likelihood that participants had active suicidal ideation or suicide attempts. However, in 
the event that participants presented suicide risk or experienced severe symptoms of 
depression, a second safety measure and protocol was designed. This protocol was called 
‘Monitoring of Depression and Risk of Suicide’.  
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Monitoring of Depression and Risk of Suicide protocol  
 In this protocol, the Study Coordinator and the CRC staff monitored participants’ 
level of depression and risk for suicide every time they came to their session. 
Participants’ depression scores were reported weekly or as needed to the PI and to the 
psychiatric staff backup in order to ensure the safety of the participants. The monitoring 
process for risk of suicide began immediately when the participant logged into his or her 
session and answered the Depression Self-Assessment measure (the PHQ-9) that is built 
into the ePST program.  
Immediately after the PHQ-9 was completed, the ePST program automatically 
generated a printout, and simultaneously put the session on hold. This printout included 
the participant’s PHQ-9 responses and a unique safety code number (this code differed 
for every session). While the ePST session was on hold, the Study Coordinator or the 
CRC staff (who was/were waiting outside of the room) reviewed the depression self-
assessment scores, paying particular attention to how question 9 “Thoughts that you 
would be better off dead, or of hurting yourself” was answered. ePST sessions remained 
on hold until the Study Coordinator or CRC staff entered the safety code and clicked the 
continue button. The Study Coordinator or CRC staff inserted this safety code number 
only if there was no indication of suicidality. On the other hand, if a participant answered 
question 9 with a score higher than 1 (on a 0 to 3 scale), the Study Coordinator and/or the 
CRC staff followed the procedural manual for safety (see Appendix 5).  The printout 
served as a guide so the Study Coordinator could monitor participants’ severity of 
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symptoms and presence of suicidality. Note: For a detailed description of this process, 
see Appendix 6. 
Procedural Manual for Safety – Clinical Coverage 
A third safety measure was called Procedural Manual for Safety. This manual 
guided the PI, the Study Coordinator, and the research staff (e.g., CRC personnel) on 
what to do in the event that a participant reported suicidality. The procedural manual for 
safety was implemented immediately if participants reported suicidal ideation, suicide 
attempts, or other self-injurious behavior during the intake process, the course of their 
study participation, or during any session. As explained in the procedural manual for 
safety, regardless of the severity of the plan or ideation, the Study Coordinator and the 
CRC staff contacted the study medical back-up. This team then proceeded with the 
necessary and standard diagnostic procedures and therapeutic interventions, as needed. 
Note: See the detailed description of the procedural manual for safety in Appendix 5.  
Monitoring for Clinical Deterioration  
A fourth safety measure was the plan for participants who experienced clinical 
deterioration during the study. Although it was unlikely that participants deteriorated 
clinically as a result of interacting with the ePST software, there was a possibility that 
factors external to the study may cause them to experience clinical deterioration.  
Through this plan, multiple measures were developed to address the possibility 
of clinical deterioration and to guarantee participants’ safety. The first measure was the 
ongoing monitoring system built into the ePST software, which alerted the study 
personnel to observe participants’ depression levels, symptom severity, and risk of 
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suicidality throughout their participation. This built-in monitoring system allowed study 
personnel to track participants’ symptoms during their participation and thus facilitate 
rapid responses to potential risks.  Participants were evaluated with the PHQ-9, which 
stratifies depression on five levels (Minimal, Mild, Moderate, Moderate-Severe, and 
Severe). Individuals who scored in the severely depressed range (21 to 27) for two 
consecutive sessions were excluded from the study (See Vignette 1). Similarly, ePST 
participants were excluded if their overall depression score increased two levels within 3 
consecutive sessions (See Vignette 2).  
 (Vignette 1): Participant X scored 10 points in his intake 
session (Moderate Depression). Participant X scored 21 
(Severe Depression) in sessions two and three. 
(Vignette 2): Participant Y scored 7 points (Mild 
Depression) in his intake session. He scored 13 points 
(Moderate Depression) in session two and 19 points 
(Moderately Severe Depression) in session three.  
In either event, participants were referred immediately (i.e. within 10 minutes of 
observing the increased score) to the psychiatric backup for a face-to face evaluation. In 
these circumstances, participation in the study resulted in suspension.  A referral was 
made for treatment; however, the data was included in the final analysis.  
Note: Regardless of participants’ levels of depression, deterioration, or symptom severity, 
an affirmative response to question 9 (“thoughts that you would be better off dead or of 
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hurting yourself”) or report of suicidality at any point in the study resulted in the 
implementation of the procedural protocol for safety.   
Other measures to ensure that professional help was available to the participants at 
all times included the Monitoring Risk for Suicide Protocol (Appendix 6), the Procedural 
Manual for Safety (Appendix 5), and the physical location of the clinical trial (i.e. at the 
BIDMC- CRC facility). 
Note: Protocols to respond to participants who reported any level of suicidal ideation, 
severe levels of depression, and/or clinical deterioration are provided in the following 
appendices:  
 Appendix 5- Procedural Manual for Safety  
 Appendix 6- Monitoring for Depression and Risk of Suicide protocol 
Measures 
Demographic questionnaire: Information was collected on participants’ age, 
ethnicity, sex, educational level, and computer frequency usage. 
Depression Measures 
Patient Health Questionnaire (PHQ-9) (see Appendix 4, letter A): The PHQ-9 is 
the 9-item depression module from the full PHQ. The PHQ-9 was used for two reasons, 
including: 1) Participant selection and, 2) Monitoring depression levels in the ePST group 
in each session. The PHQ-9 was designed for depression screening and has been 
validated with 3,000 primary care patients. Responses for these 9 items (from the DSM-
IV) range from 0 for “not at all” to 3 for “nearly every day.” A total score is calculated by 
adding the scores for each of the 9 symptoms. Higher scores indicate greater depression 
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symptom severity. As a severity measure, the PHQ-9 score can range from 0 to 27, since 
each of the nine items can be scored from 0 (not at all) to 3 (nearly every day). The 
psychometric properties of the PHQ-8 are nearly identical to those of the complete PHQ-
9 (Corson, Gerrity, & Dobsha, 2004); it possesses excellent sensitivity (.97), specificity 
(.97), and positive predictive value (.75) for detecting major depression (Kroenke & 
Spitzer, 2001). 
Beck Depression Inventory II (See Appendix 4, letter B): The Beck Depression 
Inventory Second Edition (BDI-II) is a 21-item self-report instrument used to assess the 
existence and severity of symptoms of depression as listed in the American Psychiatric 
Association's Diagnostic and Statistical Manual of Mental Disorders Fourth Edition 
(APA, 1994). There is a four-point scale for each item ranging from 0 to 3. The cutoff 
scores are: 0-13 - minimal depression; 14-19 - mild depression; 20-28 -moderate 
depression; and 29-63 - severe depression (Beck et al., 1996). The psychometrics of the 
BDI-II are quite sound. BDI-II has a Coefficient alpha of .92 with outpatient and 0.93 
with nonclinical samples, and the test-retest reliability coefficient across the period of a 
week of 0 .93 (Beck, 1988; Dozois, et al., 1998). The BDI-II was used as the primary 
outcome measure of depressive symptoms and to monitor depressive symptoms 
throughout treatment. BDI-II was used during the three data points: intake, mid-point and 
post-test session in both treatment conditions. 
Hopkins Symptom Checklist 20-item Depression Scale (HSCL-20-d)(see Appendix 
4, letter C): The HSCL-20-d is a validated self-reported measure of depressive 
symptoms, and functioned as the primary, self-report measure of depressive symptoms in 
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the present study. This 20-item depression scale (Katon et al., 1995) is derived from the 
90-item HSCL (Lipman, Covi, & Shapiro, 1979). Items are rated on a 5-point scale (0 to 
4) according to how much the symptom has been experienced during the past week. Scale 
scores are determined by dividing the sum of the items by the total number of items, 
yielding a range of 0-4.  A Score of 1.72 has been shown to be associated with a high 
positive predictive value for a diagnosis of major depression in adult primary care 
patients (Mulrow et al., 1995).  
The HSCL-20-d item scale has been used in other studies that used Problem 
Solving Treatment. Thus, the results of the present study allowed for comparisons with 
other PST studies.  The HSCL-20-d has also been shown to be a valid measure of 
depressive symptom improvement (Katon et al, 1995, 1996, 1999; Ware, 1996), and has 
been used as the primary outcome measure in many depression collaborative care studies, 
including IMPACT and RESPECT-D, thus allowing for direct comparisons between 
studies (Hegel et al., 2003). The HSCL-20-d with depressed adults has a coefficient alpha 
of .86 (Williams et al., 2004).   
Mini International Neuropsychiatric Interview (MINI): The MINI is a brief, 
structured diagnostic interview that assists in the diagnosis of psychiatric disorders, based 
on DSM-IV and ICD-10 diagnostic criteria. It is used only to establish eligibility for the 
study. In the MINI, if a participant answers key questions negatively, the participant 
‘skips out’ of that section. If the subject responds positively to one or more of the key 
screening questions, more detailed questions are then asked. The MINI demonstrates 
strong diagnostic concordance with the Structured Clinical Interview for DSM-III-R 
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diagnosis of major depression, with a Cohen’s kappa of 0.84; in addition, the MINI has 
an excellent inter-rater reliability (.75to .80) and test-retest reliability (above .75) 
(Sheehan et al., 1997; Sheehan et al., 1998). The MINI was used in the enrollment 
interview and in the post-treatment session.  
System Usability Scale (SUS) (see Appendix 4, letter D): The System Usability 
Scale (SUS) is a 10-item self-report measure of the ease of using computer programs with 
odd-numbered items worded positively and even-numbered items worded negatively. 
Items are scored on a 5-point scale (0-4) on the strength of agreement with each of 10 
statements (e.g., “I found the system unnecessarily complex”, “I felt very confident using 
the program”). Cronbach’s alpha for inter-item agreement is a robust 0.91 (Bangor, 
Kortum, and Miller, 2008). Factor analysis shows only one significant factor, suggesting 
that the overall score is the best measure of usability. The sum of the individual items 
(range 0-40) is multiplied by 2.5 to obtain the total score, ranging from 0-100. SUS 
scores that are 68 or higher are at least average, while scores below 68 are below average 
(Sauro, 2011). The SUS scale was built as part of the ePST software and was 
administered to the participants at the end of sessions 1 and 6 in the ePST group. 
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CHAPTER 4: RESULTS 
SPSS (version 21.1 for Windows) was used to conduct all the quantitative 
analyses. The primary outcome variable—depression—was measured using the BDI-II 
and the HSCL-20-d.  
Demographic characteristics at the Pre-screening phone interview and at the In-
Person Screening 
Of the 100 responders to the advertisements, 97 were pre-screened. In the pre-
screening phone interview 33 participants were excluded, 23(70%) were male and 
10(30%) were female. Among the 33 participants, 12 (37%) were African American, 11 
(34%) were Caucasian, 3 (9%) were Hispanic / Latino, 2 (6%) were Asian, and 2 (3%) 
reported being Other. The average age mean for males was 36.8 (SD= 14.1) and for 
females was 36.8 (SD=8.31). Among these 33 participants, 25(75%) were excluded from 
the study due to having psychotic symptoms. Another 4(12%) were excluded because 
they reported having problems with substance abuse, and the last 4(12%) were excluded 
because they were in psychological therapy at the time.    
An additional 19 individuals from the original 97 pool were excluded during the 
In-Person intake screening (18 male and 1 female). 8 (42%) were African American, 7 
(37%) were Caucasian, 2 (11%) were Hispanic / Latino, 1 (5%) was Asian, and 1 (5%) 
reported being Other. The average age mean among these males was 29.5 (SD= 10.2) and 
for the only female was 45 (SD=0). Among these 19 participants, 11 (75%) were 
excluded because they had suicidal ideation and attempts in the past, 4 (6%) were 
excluded because they did not want to be part of the study (i.e., not willing to wait six 
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weeks to start the program) and another 4 (6%) were excluded because the clinical study 
did not meet their expectations (i.e. thought they would be receiving anti-depressants). 
Demographics of the final Study sample  
After applying inclusion and exclusion criteria, forty-five participants completed 
the study trial.  28 (62%) were women and 17 (38%) were men. The women’s average 
age was 30.36 (SD=7.91), and the men’s average age was 26.74 (SD= 10.38). Regarding 
ethnicity, 65% of the participants were Caucasian, 22% were Hispanic/Latina, 9% were 
African American, while 4% were Asian. The level of education of the participants was 
divided in the following manner: 33% have some college or associate’s degree (most of 
them were in college at the time), 31% were college graduates, 25% were postgraduates, 
7% did not complete high school, and 4% were high school graduates. Finally, 42% of 
the participants reported using the computer more than 3hrs. a day but less than 5hrs, 
22% reported using the computer more than 8hrs. a day, another 22% reported using the 
computer less than 1hr. a day, and finally 13% of the participants reported using the 
computer more than 6 hrs. but less than 8hrs. a day. 
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Table 2. Study’s Descriptive Demographics 
 
Retention Rates 
Of the 45 participants who agreed to participate and met study criteria, 100% 
completed the three time assessments. Attrition rates were significantly higher even 
though these numbers (e.g. attrition and dropout rates) did not correspond to what the 
computerized intervention literature has reported (i.e., dropout rates of 20% to 50% 
 63 
(Christensen & Griffiths, 2002; Christensen et al., 2006; Perini et al., 2009). These 
numbers are discussed in the results and discussion sections further below.  
Figure 1. Flow of participants throughout the clinical trial 
 
Diagnoses and Depression level 
All participants (N=45) met the cut-off criteria between 10 and 20 on the PHQ-9, 
(with a M=14, SD= 2.9), indicating a moderate level of depression. By post-treatment, 
the mean score of 8 indicated that the depression levels were in the non- depressed range. 
Participants’ scores of depression measured by the Beck Depression Inventory-II, at 
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Baseline with an M= 21.9, SD= 4.32, reported a moderate level of depression. 
Additionally, participants’ scores on the HSCL, at Baseline with a mean of 1.5, SD=0.5, 
expressed mild to moderate levels of depression as well.  Finally, the results of the 
structured clinical interview showed that 70% of the participants met the criteria for 
Major Depressive Disorder, 20% met comorbidity diagnosis of Depression with Anxiety, 
5% met diagnosis of Dysthymia while just 1% met diagnosis for PTSD. 
Statistical analyses were performed on all participants that completed the study.  
Preliminary Analyses 
Preliminary analyses were conducted prior to testing the study hypotheses. The 
descriptive analyses of the data were inspected (including frequencies, means, standard 
deviations, skewness, and ranges of values) to determine accuracy of entry and to look 
for outliers. The analyses were based on the intention-to-treat principle (i.e. those who 
provided follow-up data irrespective of treatment adherence). 
Scatterplots and boxplots of the data were checked.  Results in this phase showed 
that data met the assumptions of normality. These results were confirmed with visual 
representation of the boxplots and scatterplots indicating no outliers and with the 
transformation of the raw scores into Z-scores Z<2.5.  
Table 3. Descriptive statistics for the outcome measures by time assessments points 
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Intervention efficacy 
To provide context to our findings, we hypothesized the following: 1) Depressive 
symptoms will not be different between groups across time assessments, 2) Depressive 
symptoms would not show significant improvement over time, and 3) There would not be 
a treatment interaction between groups across the three time assessments (i.e. pre, mid-
point, and post-treatment). 
To test the main hypotheses, multiple repeated-measures analyses of variance 
(ANOVA) were performed. The means of BDI-II and HSCL were used to test for 
significant difference between groups.  Partial eta square (η2) was computed as a 
measure of effect size. There were only two levels of factor A (i.e., ePST and DEC). 
Alpha level was set at .05 
As presented in Figure 2, there was a significant time effect observed for the BDI-
II outcome. Importantly, there was a significant Group x Time interaction effect 
suggesting that the patients receiving ePST had a significantly greater improvement 
compared to the patients in the DEC group.   
Baseline Mid-point Baseline Mid-point
Post-
Treatment
M SD M SD M SD M SD M SD M SD F P-value
Effect 
sizze, d
BDI-II 21.75 4.24 22.5 5.76 23.3 5.6 22.04 4.46 18.04 4.22 14.52 3.73 58.78 0.001 0.57
HCLS-20-d 1.47 0.49 1.49 0.49 1.6 0.46 1.54 0.53 1.43 0.43 1.2 0.41 24.91   .001. 0.36
Post-Treatment
Test StatisticsDelay Entry Control ePST
Table 3. Descriptive Statistics for Outcome Measures by Time Assessment Points 
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The main difference in the ePST group happened between Baseline and Mid-
point, and continued decreasing between Mid-point and Post-treatment.  Mean 
differences among the three testing occasions were tested for statistical significance. 
Effect sizes were examined using partial Eta squared. Mauchly Test of Sphericity was 
used to test for homogeneity of covariance across the three levels of the within groups 
factor.  The Mauchly test of Sphericity sets the alpha level at .05; however, this test was 
significant (p < .29), therefore the Greenhouse-Geisser test was used to test homogeneity 
of variance and modify the ANOVA F. The Greehouse-Geisser test indicated a p= .866, 
which is sufficient to fail to reject the null hypothesis.  There was a significant Time x 
Group interaction effect: F (1.73, 43)= 58.78; p <.01; η2 = .578, which indicates a ‘large’ 
effect (Kinnear & Gray, 2010). 
Pairwise mean comparisons were performed for the Time factor using the 
Bonferroni procedure. The Bonferroni test was used because we planned to have multiple 
comparisons protecting the inflation of the alpha level. The familywise significant level 
was set at .05. There was a significant reduction in the BDI-II scores from Baseline to 
Mid-Point (MD=1.67; p < .001) and from Baseline to Post-treatment (MD= 3.0; p < 
.001). We also observed a significant reduction on the BDI-II scores between Mid-point 
and Post-treatment assessments (MD= 1.32; p < .001). The 95% confidence intervals for 
the values of the population mean difference were: 0.58 to 2.76; 1.87 to 4.12; and 0.53 to 
2.14 according to the group order above. 
Group differences across times were analyzed, and results indicated a statistical 
difference between groups F (1; 43)=11.81; p< .001; η2 = .216. Post hoc test showed 
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simple main effects to be significant at Mid-Point assessment F (43,1)=10.04, p< .003, 
and at Post-Treatment F(43,1)=41.73; p < 0.001), but no significant at Baseline F (43,1) 
= .02; p < 0.89.  
Figure 2. Beck Depression Inventory-II scores 
 
 
 
In regards to the HSCL-20-d outcome measure, the statistical analysis of the 
means showed a significant interaction between Time x Group, as is illustrated in Figure 
3. Effect sizes were then examined using partial Eta squared. Mauchly Test of Sphericity 
was used to test for homogeneity of covariance across the three levels of the within 
groups factor; however, this test was significant (p=0.001), therefore the Greenhouse-
Geisser test was used to test homogeneity of variance and modify the ANOVA F. The 
Greehouse-Geisser test indicated a p= .781, which was sufficient to fail to reject the null 
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hypothesis.  There was a significant Time x Group interaction effect: F(1.56, 43)= 24.91; 
p <.001.; η2 = .36, which indicates a ‘moderate’ effect (Kinnear & Gray, 2010). The test 
between-subjects groups were not significant at the 0.05 level (p = .32). Although there 
was a reduction in the HSCL-20-d scores between Baseline and Mid-Point (MD=0.03; p 
< .92) and between Baseline and Post-treatment (MD= 0.09; p < .075), as well as 
between Mid-point and Post-treatment assessments (MD= 0.49; p < .109) the Pairwaise 
comparison test, using Bonferroni, showed no significant differences between the Time 
factor. The 95% confidence intervals for the values of the population mean difference 
were: -0.54 to 0.13; -0.006 to 0.18; and -0.007 to 0.10 according to the group order 
above.  
Finally, group differences across times were analyzed and results indicated no 
statistical difference F(1,43)= 0.88; p <.035; ŋ2= 0.020. Post hoc test found no 
difference between groups at Baseline F(43,1)= .23; p < .633 and at Mid-Point F(43,1)= 
0.23; p < .634; however, a main effects at the Post-treatment assessment point was found 
F (43,1)= 9.71; p < .003.  
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Figure 3. Hopkins Symptoms Check list- 20-d 
  
 
In summary, the clinical trial showed that participants in the ePST group 
improved their depression symptoms (from Moderate to Mild levels of depression) after 
receiving 3 session of ePST, as well as after receiving six session of ePST (from 
moderate to minimal levels of depression). On the other hand, participants that were 
assigned to the DEC group remained with Moderate levels of depression for seven weeks. 
The difference between the groups suggests that ePST, a computerized evidence-based 
intervention for depression, showed a significant improvement to treat symptoms of 
depression after four weeks and six weeks of use. 
User Satisfaction and Program Usability 
We also hypothesized that ePTS would be perceived as user-friendly. To test this 
hypothesis, the SUS score means were examined to determine whether the subjects found 
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the software treatment to be user-friendly or not. In Table 2, the group mean and standard 
deviations were reported for the overall average rating of user-friendliness, and means 
and standard deviation were reported for each question.  
Table 4. Summary of the System Usability Scale scores 
 
Participants  (N=25) rated ePST using the SUS at Week 1(M= 76.6, SD= 7.17) 
and Week 6. (M=85.4, SD=5.62) on a 1-100 scale. The T-test was performed to 
determine significant changes between time points. Results showed that these changes 
were significant t(24)= -9.60; p< 001. The statistical results also indicated that 
participants found the program (i.e., ePST) to be usable. According to Bangor et al., 
(2008) in their meta-analysis, suggest that the average system score is 70 points, while 
Sauro (2011) suggested 68 points to be considered as average. In either case, the present 
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scores put ePST in the Good to Excellent range. Furthermore, these scores were 
consistent with another two studies where ePST was evaluated for its user-friendliness 
(Cartreine et al., 2013; Berman et al., 2014). 
 
Qualitative analysis  
To further understand the study’s results and the efficacy of ePST to treat 
symptoms of depression, a semi-structured, open-ended interview was conducted at the 
end of the study with participants who used ePST. The goal of this debriefing session was 
to find out what the participants liked or disliked about the software, and to give them an 
opportunity to suggest improvements to the program. Of the 25 participants who 
completed ePST, 11 agreed to be part of this qualitative component. The interview 
focused on the following questions: 1) what were the things that you liked about the 
program?, 2) what are the things that you would change/improve in the program?, and 3) 
What things/factors do you think helped you improve your depression?  
Things that participants liked about the ePST  
Overall, participants found ePST easy to use and easy to interact with. 
Participants liked how straightforward and accessible the ‘virtual therapist’ presented the 
steps to identify and work on each of their problems. This feature allowed participants to 
have control over the time they would dedicate to their own problem solving each week. 
Participants also liked that they could choose what problems to work on instead of being 
told what to do. Furthermore, participants valued the idea of not having a ‘time limit’ in 
their session instead of feeling rushed through the time as in traditional face-to-face 
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therapy. Additionally, they also liked not having the pressure to talk about things that 
they were not ready to talk about. Another feature that was highly valuable was the fact 
that participants could go back and forward between the content, in other words, if they 
needed more time to process or better understand what the ‘therapist said’ they could 
pause the session without having to worry about losing time or waiting until the next 
session.  
 
Things to improve in ePST  
Participants suggested improvements to ePST regarding: Generalization, Limited 
Interaction, and Portability.  
Generalization: participants sometimes felt that the intervention needed to be less 
computer-like and more human, meaning being more approachable and personal. For 
example, some of the participants would have liked to hear their name at the time of the 
greeting or when terminating the session with the virtual therapist. 
 Limited interaction: Some participants reported wanting to have additional 
interaction with the ‘virtual therapist’ (e.g., to consult other personal issues or to follow-
up on other questions, alternative treatment plans and unresolved issues). For that reason, 
they suggested to complement ePST with a type of “live online chat” or “hotline” so they 
could discuss other issues that required a higher level of support (e.g., which services are 
the right ones for their situation). Also, they recommended using voice commands versus 
typing.  
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Portability: Although participants knew ePST was tested in a controlled clinical 
trial, they suggested, for practical reasons, that ePST should be accessed through the 
Internet instead of having to use a flash drive. Participants thought that having ePST on 
the web would give them real freedom to use and access the intervention ‘virtually’ from 
anywhere, at any time, and through various means (i.e., laptop and smartphones) instead 
of having to carry a flash drive with them all the time. 
During this interview another concern raised was the protection and confidentially 
of their personal information, and even though it was not part of ePST, it would be 
relevant to consider in the future. The majority of the participants reported feeling 
“ambivalent” on sharing too much information about their psychological problems to the 
computer because they know “that once you put something on a computer it will, or 
could, become public access”. Along the same lines, another fear reported was that third 
parties could have access to their records, and as such they could be labeled as 
‘psychiatric patients’ and charged more from their insurance policies.  
 
Things/Factors that helped them improve in their depression 
Multiple factors were reported by the participants to be helpful in decreasing their 
levels of depression during the clinical trial. First, doing the study in a specialized 
research center where professional clinical help was available 24/7, allowed the 
participants to have control over their time. This notion was illustrated when one 
participant said, “I am finally able to schedule my therapy at a time that is most 
convenient to me and not to my therapist”.  
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A second factor was that participants where encouraged to work on short-term 
and achievable goals instead of long-terms goals. When participants achieved their short-
term goals, they not only experienced gratification—something important to feel 
especially if you are depressed – but also, they found that they could solve problems even 
though they were depressed. For example, a participant said, “I have been depressed for 
months and I am used to thinking that I can’t do anything right because of my depression, 
but when I solved my first goal I realized that even though I am depressed I can do 
things… that made me feel happy and hopeful and also made me think that not 
everything is lost”.  
 A third component was acceptance of their depression. Acceptance of their 
symptoms was present when participants were not excluded from the trial either because 
they were too depressed or because they did not want to take medication. The following 
statement illustrates how acceptance motivated a participant to work on their depression:  
“When I found that I was not rejected from the study because of my depression (i.e., 
moderate-severe depression) I felt hope because I was recently rejected from another 
depression study because ‘they’ found me to be too depressed to treat me… that made me 
feel that I was a lost cause and that I was really sick”.  
The last factor that participants found valuable was validation of their depression. 
Validation occurred in every session when participants checked in with the virtual 
therapist about the progress of their problems, as well as when they received tailored 
feedback about their levels of depression. This feedback helped participants to be aware 
of their thoughts, emotions, and behaviors by helping them monitor their symptoms as 
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well as thinking about other action plans that they could use to improve their depression. 
For example, a participant mentioned, “I always felt that my symptoms and my 
depression were something bad…but when I started my therapy I noticed that regardless 
of the severity of the depression the ‘virtual therapist’ always had a neutral and objective 
point of view and that made me feel that depression is something common, is treatable, 
and curable and is not an impossible mental health condition to overcome. I felt normal, 
and accepted by the Mark ( the virtual therapist).  
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CHAPTER 5: DISCUSSION 
Summary of the Overall Study 
The current study was a randomized clinical control trial of a new computerized 
treatment intervention to reduce symptoms of depression in the adult population. 
Participants in the treatment group (ePTS group) received six sessions of the electronic 
Problem Solving Treatment (ePST), while participants in the Delayed Entry Control 
(DEC) group waited six weeks to receive ePST.  An experienced clinician conducted the 
clinical interview, and depression measures were obtained to diagnose and detect 
symptoms of depression, as well as other psychological/ psychiatric illnesses. Overall, 
results indicated that ePST is an effective treatment to reduce symptoms of depression.  
Summary of Study Results 
Results indicated that depression symptoms in the ePST group significantly 
improved by the Mid-point time assessment and continued after the post-treatment time 
assessment. On the other hand, depression symptoms were maintained in the same level 
range (moderate to high) for the DEC group over the same time assessments, as indicated 
by the Beck Depression Inventory- II and the Hopkins Depression Checklist-20-d. The 
changes between groups regarding their depression symptoms are consistent with the 
Problem Solving Treatment literature (Barrett et al., 1999; Dowrick et al., 2000; 
Williams, 2000; Berman et al., 2013) and with several clinical trial studies that have used 
computerized evidence-based treatments to treat depression symptoms  (Proudfoot, 2003; 
Warderam et al, 2008;Anderson, 2008; 2009; Meyer et al., 2009). 
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Treatment effects  
  
Results indicated that ePST is an effective psychological treatment to treat adults 
who had moderate to moderate-severe levels of depression after three and six sessions. 
The efficacy of ePST to reduce symptoms of depression after three sessions is consistent 
with other studies where young adults and adults with depressive disorders improved 
their symptoms after 3 ½ hours of using problem solving therapy (Mynors-Wallis et al., 
1995; Mynors-Wallis 1996). Additionally, the results from this study reinforced the 
notion that Problem Solving therapy, (either delivered face-to-face or via computer) is 
more effective when compared with no treatment, treatment as usual, and attention 
placebo for treating major depressive disorders (Cuijpers, van Straten et al., 2007; 
Malouff, Thorsteinsson, & Schutte, 2007). Also, these results prove that problem solving 
therapy can be administered in primary care settings by non-mental health professionals 
while still being an effective way of treating adults who suffer from depression (Mynors-
Wallis, Gath, Day, & Baker, 2000). Additionally, these results are in line with other 
clinical trials where problem-solving therapy delivered via computer was seen to be as 
effective as face-to-face problem solving therapy (Kaltenthaler et al., 2008). Finally, 
these treatment results are consistent with a recent clinical trial that used ePST (Berman 
et al., 2014) to treat depressed patients. 
Attrition rates   
 
Our attrition rate of 100% should not be considered unusual when compared to 
similar computerized studies for depression. For instance, in a systematic review of 
computerized cognitive behavior therapy (CCBT) for depression, Kaltenthaler et al. 
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(2008), reported dropout rates for CCBT ranging from 0% to 75% in their studies. 
Furthermore, a recent study conducted by Berman et al., (2014) that used ePST, showed 
an attrition rate of 87%. Nonetheless, this 13% attrition rate difference in our ePST study 
could be attributed to the fact that our clinical trial had three study coordinators dedicated 
to the recruiting and monitoring of participants appointments. Therefore, these results 
should be interpreted with great caution.  
However, it has been shown that internet and computerized interventions 
combined with live therapist support (i.e., interacting with study personnel) yield better 
outcomes and greater retention rates (Johansson & Andersson, 2012).  
In summary, the study results concluded that ePST is an effective intervention to 
treat Caucasian women who are highly educated (i.e. at least some college) and who 
suffer from Moderate-Severe levels of depression.  
 
STUDY LIMITATIONS  
This clinical trial possesses multiple strengths and benefits; however, it is 
necessary to recognize its limitations and for that reason some cautions in interpreting the 
study findings are offered. The first limitation is based on the study sample and its 
demographics, including: educational level and computer skills, and the chosen targeted 
population.  
Educational level and computer skills: Subjects were recruited through different 
media venues (e.g., flyers, emails, PCP referrals, word-of-mouth) and in diverse settings, 
although the majority of the participants who completed the study were college students 
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(i.e., undergraduate or higher level) and professional workers. Having an educated study 
sample, as occurred in this study, has been a common observation in computerized and 
Internet trials (Andersson and Titov, 2014; Beneling et al., 2011) across the board. These 
results could skew the outcome measures, as well as the attrition and dropout rates. For 
example, it is known that a typical CBT language has a reading age level of 17 years 
(Willliams & Garland, 2002) therefore; this may create a barrier for many individuals. 
Although, participants in this study were assessed for reading fluency using The Saint 
Louis University Mental Status Examination (SLUM), study results showed that 
participants with higher educational levels present with higher attrition rates, and gave 
higher scores to the ePST regarding its user-friendliness while participants with lower 
educational level gave lower scores to the same rubric.  Although such demographic 
characteristics may reflect a higher socio-economic status (e.g., highly educated and 
having access to the Internet), it also raises the question about whether the characteristics 
of patients using this type of treatment interventions are similar to those accessing 
traditional face-to-face treatment in primary clinics (Anderssson and Titov, 2014). 
Nevertheless, this study proved ePST’s efficacy to treat symptoms of depression and it 
also indicates that ePST, at this time, like other computerized interventions, needs to be 
tested with clinical groups and/or with groups that have lower educational backgrounds in 
order to assess reach. However, interpretation of these findings should not be generalized 
across different education and computer literacy levels.  
  On the other hand, the study’s attrition rate could be explained by the level of 
education of the sample and by the design recruitment system design. As the literature 
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has shown, highly educated individuals tend to participate more in this type of 
computerized and Internet clinical interventions, thus it is common to observe high 
proactivity in their own recruitment and more motivation to participate in treatments; 
hence participants are more responsive (Andersson and Titov, 2014). Although more 
research is needed to draw definitive conclusions, this study offers valuable clinical 
implications for those Internet-based self-help treatment developers.  
In summary, the majority of the studies in this field have been carried out with 
English-speaking individuals of higher socioeconomic status and educational levels 
above high school. Furthermore, additional research seems to be needed on the socio-
ethnic-educational mismatch among computerized interventions. As is noted above, it is 
possible that this mismatch was a factor on the treatment effects by groups.  Even though 
there have been few studies on this issue (Choi et al., 2012), there is very little research 
on this topic and further exploration is required. Until these interventions overcome the 
cultural, educational, and language barriers it cannot be determined if these innovative 
therapeutic interventions are a viable solution to treat mental health problems among 
different socio-demographic groups. 
Another limitation is the use of self-reported measures (BDI-II, PHQ-9, and 
HSCL-20-d).  Although all these measures are widely used in clinical trials and are 
practical tools to detect the severity of symptoms of depression, the accuracy and 
usefulness of the instruments depends on the individual’s ability to rate him or herself 
accurately. This limitation might cause responders to skew their answers since some 
subjects may find the label of being depressed too strong; therefore, subjects may present 
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themselves in a positive light: more competent or in a better psychological state than they 
actually are; and thus their results may not be comparable across individuals. This has the 
potential to introduce bias as those who received the intervention may report 
improvement if for no other reason than being aware that they are expected to improve. 
The reliance on self-report measures might cause a bias on the impact of the intervention 
regarding participants’ depression symptoms.   
Although efforts to minimize this limitation were addressed in the study, (i.e., 
participants were clinically diagnosed by an experienced clinician before and after the 
trial using a clinical structured interview) study findings are based on self-reported 
measures, which are comprised entirely of participants’ competency to complete self-
reported surveys.  In summary, online questionnaires work well and are helpful to the 
therapist to detect risks but psychiatric diagnoses cannot be reliably made using self-
reported measures (Adersson and Titov 2014). 
In addition to the self-reported measures and the possible limitations due to the 
nature of the targeted population, another limitation is the type of intervention by group. 
As is set in the study design, participants in the ePST group received the interventions for 
depression, while participants in the Delay Entry Control group did not receive any 
treatment. Even though several studies have used this methodology (treatment vs. waitlist 
or sometimes called treatment as usual) this is a considerable study limitation. The 
implication of this limitation lies in the possibility that it is easier to find a significant 
difference between treatment conditions. In other words, getting something is better than 
nothing.  This effect is called a placebo effect.  According to recent theories on the use of 
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placebo in clinical trials with patients who suffer from pain and from depression, placebo 
will affect the psychosocial context that surrounds the patient (Koshi & Short, 2007) and 
thus this context can play an important role in the outcome of treatment. In other words, 
if the patient perceives the study facilities as positive, the patient will feel better 
regardless of the intervention.  The opposite is true as well, if the patient perceives the 
study facilities negatively, these too will have an impact on the patient’s experience and 
performance.  
One way to address this problem is by comparing ePST treatment versus self-help 
book intervention for depression for the same amount of sessions and through the same 
mechanisms (via on-line or via flashdrive). In that case, both groups would receive 
something that has been proven to work for depression and thus, the study will be able to 
show if there is a statistically significant improvement in one group over the other.  By 
controlling the interaction of different treatments, a study could deduce if the results were 
caused by the ePST intervention and not by other factors. 
Finally, three assessment points, in a seven week study, seems like a relatively 
short time to evaluate the efficacy of the intervention, in particular in assessing subjects’ 
changes in their depression between the mid-point (week 4) and post-treatment (week 7) 
assessment times. Nevertheless, the Problems Solving Therapy literature has argued that 
patients who received PST will show significant improvements in their depression 
symptoms by the end of their third session (Berman et al., 2014).  
In addition to this evidence, a recent meta-analysis on computerized interventions 
conducted by Warmerdam et al. (2008) and another study by Van Straten et al. (2008) 
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have highlighted that many participants have shown rapid improvement within the first 
five weeks of treatment.  A similar study conducted by Meyer et al., (2009) observed 
lasting therapeutic effects on patients that received a fewer number of sessions. Finally, a 
meta-analysis conducted by Van Straten et al., (2008) and by Warmedarm et al., (2008) 
showed that treatments with less than 8 sessions showed similar treatment effects to those 
studies that have 8 sessions. Even though treatment effects are significant in this study, 
researchers in the field of computerized intervention have suggested conducting studies 
that incorporate longer follow-ups in order to detect the long-term treatment effects of the 
interventions (Chistensen et al., 2004); (Mackinnon et al., 2008), since these are lacking 
in the field. Therefore, further research with longer follow-up periods is needed, in 
particular because help-seeking and health care users might be affected over time as an 
effect of treatment (Christensen, Leach, Barney, Mackinnon, & Griffiths, 2006). 
The last limitation of the study consists of the amount of interaction that 
participants had with the study personnel. Although we made several efforts to have 
minimal contact with participants (i.e., less than 3 min. per session) direct contact (e.g., 
make appointments, meeting with study staff during the time assessments, and meeting 
with professional mental health providers when participants reported being suicidal) and 
indirect contact  (e.g., receiving emails by the study personnel to remind them about 
appointments) should be considered as external factors that could have influenced the 
treatment outcomes.  
 Therefore, our findings should be interpreted taking into account these 
interactions at the time to determine whether ePST could be used as a stand-alone 
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intervention for depression or as an adjunct treatment for depression. Furthermore, more 
research is recommended to determine the therapeutic status of ePST ™ 
In summary, despite the limitations described herein, the results of this 
randomized clinical control trial provide support for the significance and value of ePST 
as an evidence-based treatment intervention based on Problem Solving therapy to treat 
depression in adults. Further evaluation of this intervention is recommended in order to 
maximize its utility and impact. 
POTENTIAL BENEFITS  
It is not surprising that the World Wide Web could be the channel to reach 
individuals who present anxiety and depression symptoms worldwide, and that Internet 
interventions could be the solution to treat them. Given that health care is one of the most 
common reasons for using the Internet (Powel and Clarke, 2002), individuals with 
anxiety and depression are particularly likely to seek information and resources online 
(Berger, Wagner and Baker, 2005). 
Internet-based interventions report multiple benefits, including: (1) being used as 
diagnostic tools (Slack et al., 1966; Robison et al., 1998; Budman, 2000; Muñoz, 2010), 
(2) as adjuncts to or as stand-alone treatments in health care facilities. For example, 
primary care physicians, non-mental health and mental health specialists can use these 
interventions during assessments and as a psycho-educational tool, before, during and 
after treatment, and throughout the recovery phases (Hikie, et al., 2010, Andrews and 
Titov, 2010).   
 85 
As a primary treatment, computerized and Internet-based interventions are 
effective when health care resources are limited and when no other interventions for 
specific health problems are available (Muñoz, 2010); (3) Internet-based interventions are 
significantly cheaper in comparison with medical and psychiatric interventions, as well as 
for the maintenance of the program and the web site, and for adding new features to 
interventions; (4) interventions can be shared globally without taking resources away 
from the population where the interventions were developed (Muñoz, 2010); (5)  
accessibility decreases logistic barriers to treatment, portability and improved self-
monitoring (Newman, Consoli, & Taylor, 1999; Palmer, Bor, & Josse, 2000; Yager, 
2001), as well as reducing health care disparities; (6) Internet interventions can reach a 
mass audience, providing them with evidence-based psychological interventions 24/7, 
365 days a year across the world (Christensen and Griffiths 2002; Muñoz, 2010); (7) 
technology-assisted therapy can increase access to services from remote and isolated 
environments (e.g., International Space Station, Antarctic research base), to rural satellite 
clinics as well as state-of-the-art hospitals in metropolitan areas (Newman, 2011); and (8) 
language barriers can be reduced with the use of Internet-based interventions in primary 
care clinics, since any Internet intervention can be developed according to the patient’s 
language, sex and even race preferences, as well as in formats that do not require literacy 
(Muñoz, 2010).  
There is a pressing need to provide evidence-based treatment to persons who do 
not have access to, or choose not to access traditional mental health services. 
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Interventions delivered via electronic technologies have the potential to meet this need 
(Cartreine, Ahern, & Locke, 2010). 
FUTURE DIRECTIONS  
Depression is a common mental disorder and it is the number one cause of 
disability worldwide (Murray & Lopez, 1996). Depression also affects the course and 
outcome of common chronic conditions (e.g., arthritis, asthma, cardiovascular disease, 
cancer, diabetes, and obesity); hence, increases the medical costs to the health care 
system ranging from $30-$50 billion dollars per year (Pincus, Pechura, Elinson, & Pettit, 
2001).  Depression studies have found that between 50% to 70% of depression detection 
happens in the primary clinic sectors (Depression Guideline Paner, 1993; Munoz, Hollon, 
McGrath, Rehm, & VanderBos, 1994 (Arnau, Meagher, Norris, & Bramson, 2001). 
Despite efforts from the government and the private sector to improve access to care and 
provide quality of treatments into the health care systems to treat individuals with 
depression, data suggests that more resources are needed to fulfill the demand; therefore 
it is important to devote our efforts into the primary clinic.  
These efforts include implementation of reliable diagnostic tools (e.g., PHQ-9) 
and to provide effective evidence-based interventions that could be conducted by mental 
and non-mental health care providers as an alternative to medication treatments, such as 
Problem Solving Treatment. These interventions also need to help reduce the time and 
resources in primary care settings while at the same time have significant benefits 
treating patients with depression. Over the past two decades, the merging of evidence-
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based interventions with Telemedicine (i.e., Tele-psychiatry) has shown to be a feasible 
and reliable option to treat depression and anxiety.   
 However, although computerized and internet interventions have been found to 
have multiple benefits as previously discussed (Marks, Cavanagh, & Gega 2007), and 
have been shown to be as effective as face-to-face therapy when treating depression 
(Cuijpers et al., 2010-is guided-self-help), these interventions need further research and 
improvements before they are treated as standalone psychiatric/psychological treatments 
and before they are fully implemented in health care systems. Possible directions are 
discussed below. 
First, as has been previously discussed, one of the benefits of using computerized 
interventions is their easily portability and accessibility, as they can be delivered on flash-
drives, PCs, laptops, smart phones, and through Internet links; nevertheless, a major 
concern is their poor security system, which could lead to a breach in patients’ 
confidentiality. These therapeutic interventions seem to need to be handled as if they are 
medical devices in order to fulfill higher standards of confidentiality, and treat the 
information captured by them as if they are medical records. In other words, until 
computerized and/or Internet interventions establish a secure system where patients’ 
private information is fully protected and their confidentially is granted, computerized 
interventions will not be able to cover some of the currents gaps (i.e., lack of mental 
health providers) in the mental health care system.  
Second, despite that in the past decade several studies on the Internet and 
computerized-treatment interventions have shown the efficacy to treat depression, 
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conducting larger clinical trials in outpatient mental health clinics as well as in primary 
care settings will be required to determine and understand the real impact of these 
interventions. This could be done relatively easily since computerized and Internet 
interventions, unlike traditional therapy, can be used by hundreds and thousands of 
individuals simultaneously without losing its therapeutic power and at very low cost.  For 
that reason, it is relevant to consider the potential impact of these interventions on access 
to evidence-based mental health care in the primary care system. Also, it is important to 
determine what would be the overall cost-benefit of this model in these settings.  
Third, computerized and Internet interventions are flexible in their design by 
nature and can be adapted to reach specific target populations, including groups that 
historically have been marginalized or do not have access to care. For example, the 
program could be delivered in multiple languages (e.g., Chinese, Spanish, Portuguese and 
Russian), and its contents could be tailored to specific cultural backgrounds or to 
different levels of education. With such modifications, the effectiveness of this service 
could be investigated and possible barriers could be eliminated. Computerized 
interventions with these characteristics should be studied.  
Fourth, by definition telemedicine provides assistance in certain places where 
limited services and resources are present. In order to implement this cost-effective 
method of increasing access, it is necessary to revise the current barriers to practice 
telemedicine. One of the most salient barriers is the question of licensing. For example, 
there are restrictions to practice across states.  Furthermore, there are inconsistencies 
across states regarding regulation of telemedicine. As it is now, a number of states in the 
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United States do not provide licenses to practice telemedicine.  Once the licensing issue 
is resolved, the next challenge is how to bill for the services. At the moment, the majority 
of health insurances in the United States health care system do not reimburse for 
telemedicine services.  One possible solution, and an additional consideration for these 
interventions is the potential for these or similar interventions to be incorporated into 
collaborative care programs and/or into algorithm treatment care.  
As we know, integrated care is an evidence supported (Cochrane and Huang, 
2013) approach for treating depression in the primary care setting.  The underpinnings of 
this approach include population tracking using technology and clinical measures, 
enhancing quality of care, using a multi-disciplinary team based approach, and caseload 
consultation. Increasingly, Integrated care models, and specifically collaborative care, 
have shown enhanced clinical efficacy while creating great potential for cost saving for 
the health care system (Katon, 2012).  A critical component of the collaborative care 
model is the use of algorithmic treatment intervention.  One such model, IMPACT, does 
it this way.  Our study is not directly involved in an integrated model, however, given its 
low cost, evidence supported treatment efficacy, and flexible dissemination it lends itself 
to be an incorporated algorithm of care.  
Finally, the current study took an important first step towards the creation of a 
new computerized intervention to treat depression in primary care and possibly in remote 
and isolated environments. In addition, this study could contribute to expanding the 
current limited literature on computerized and Internet interventions available in the U.S. 
and to treat individuals living in the U.S. who currently suffer from depression.  
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In summary, this study illustrated how psychological theories, interventions, and 
technology could work together to provide quality access to individuals, most of whom 
were from higher education and socioeconomic levels. The next step in this research is 
how to tailor the intervention to those that do not have the resources to do traditional 
psychotherapy, and/or from lower education and socioeconomic levels, or to those who 
prefer other treatment options.  
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Appendix 1- Demographic Questionnaire 
Demographic protocol 
Ethnicity Hispanic Caucasian Asian African 
American  
Pacific Other  
Gender M F Other     
Age > 18: Age =        
Date of birth        
College Student Undergraduate 
Major  
Graduate 
Major  
Level of 
education 
    
Computer Skills > 
3 times a week 
Low  Mid 6 to 
7 
High >8     
Able to read and 
write English 
       
Meet the criteria      YES NO 
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Appendix 2- Medical and Psychological Exclusionary Criteria Questionnaire 
Script: I would like to ask you a couple of questions and please answer them to the best 
of your knowledge. If at any point you feel uncomfortable, you are free to stop the 
interview. 
Medical or Psychological Exclusionary Criteria 
Questionnaire  
 
 YES NO  
Have you ever had a head injury? 
If yes, did you lose 
consciousness? If yes, for how 
long? 
If yes, do you remember the 
incident? 
How long ago was it? 
Did you experience problems 
afterward? What kind? 
   
How many drinks do you have in 
a regular week? 
Cutoff 25 or more*? 
   
Ask for: the size of the glass, and 
the substance type (e.g., beer, 
liquor, etc? Generic measure/* 
   
Have you been formally Dx with 
a substance used disorder? 
   
Are you currently taking 
antidepressant medication? 
Name:  
   
Are you currently taking 
antipsychotic medication? 
   
Have you been formally D x with 
a personality disorders (e.g., 
schizoid, Borderline) 
   
Have you been formally Dx with 
bipolar, schizophrenia, brain 
damage? 
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Appendix 3- Inclusionary Criteria Questionnaire 
Inclusionary Criteria 
Script: I would like to ask you a couple of questions and please answer them to the best 
of your knowledge. If at any point you feel uncomfortable you are free to stop the 
interview. 
Inclusionary Criteria Questionnaire 
Depressed according to 
PHQ-9 
 YES NO 
How old are you?    
How often do you use a 
computer? 
 
How much time do you 
spend on a computer? 
   
Is English your first 
language? 
If not, which is it? 
Where did you learn 
English? 
For how long have you 
been speaking English?  
   
Are you receiving 
psychological or 
psychiatric treatment at 
this time? 
 
If yes, for how long? 
   
Have you been 
diagnosed with 
depression? 
If yes, When were you 
diagnosed? 
   
Are you planning to 
undergo to 
psychological treatment 
soon? 
If yes, where are you 
planning to attend? 
 
   
Administer PHQ-9, 
without item #9 (i.e., 
suicidality) 
Score 
above 10= 
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Appendix 4- Measures  
A) Patient Health Questionnaire-9 
PHQ-9 
  Not at 
all 
 
Several 
Days 
 
More than 
half the 
days 
 
Nearly every 
day 
1 Little interest or pleasure in doing things 0 1 2 3 
2 Feeling down, depressed, or hopeless 0 1 2 3 
3 Trouble falling or staying asleep, or 
sleeping to much 
0 1 2 3 
4 Feeling tired or having little energy 0 1 2 3 
5 Poor appetite or overeating 0 1 2 3 
6 Feeling bad about yourself-or that you are 
failure or have let yourself or your family 
down 
0 1 2 3 
7 Trouble concentrating on things, such as 
reading the newspaper or watching 
televisions 
0 1 2 3 
8 Moving or speaking so slowly that other 
people could have noticed. Or the 
opposite—being so fidgety or restless that 
you have been moving around a lot more 
than usual 
0 1 2 3 
9 Thoughts that you would be better off 
dead, or of hurting yourself 
0 1 2 3 
Total       
  
PHQ9 Copyright © Pfizer Inc. All rights reserved. Reproduced with permission. PRIME-
MD ® is atrademark of Pfizer Inc. 
                                 Total Score Depression Severity 
1 – 4 Minimal Depression 
5 – 9 Mild Depression 
10 – 14 Moderate Depression 
15 – 19 Moderately severe Depression 
20 – 27 Severe Depression 
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Appendix 4- Measures Contd. 
B) Beck Depression Inventory-II 
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Appendix 4- Measures Contd.  
C) Hopkins Symptom Checklist 20-item Depression Scale 
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Appendix 4- Measures Contd. 
d) System Usability Scale Measure 
SUS 
 Strongly agree                      Strongly 
Disagree 
            
1. I think that I would like to use this system 
frequently. 
           
1 
2 3 4 5 
2. I found the system unnecessarily complex.            
1 
2 3 4 5 
3. I thought the system was easy to use.            
1 
2 3 4 5 
4. I think that I would need the support of a 
technical person to be able to use this system 
           
1 
2 3 4 5 
5. I found the various functions in this system 
were well integrated. 
           
1 
2 3 4 5 
6. I thought there was too much inconsistency 
in this system. 
           
1 
2 3 4 5 
7. I would imagine that most people would 
learn to use this system very quickly. 
           
1 
2 3 4 5 
8. I found the system very cumbersome to use.            
1 
2 3 4 5 
9. I felt very confident using the system.            
1 
2 3 4 5 
10. I needed to learn a lot of things before I 
could get going with this system. 
           
1 
2 3 4 5 
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Appendix 5- Procedural Manual for Safety 
This Procedural Manual for Safety addresses the following IRB requirements: 
1. Principal Investigator (PI) and Co-Is have the responsibility to monitor all aspects of 
this study, including adverse events, on a continuing basis, and to report adverse 
events according to the IRB guidelines.  
2. PI and Co-Is are responsible for notifying the IRB at the BIDMC about unexpected 
serious adverse events (AE’s) within seven (7) calendar days.  
3. PI and Co-Is are responsible for creating the guidelines for suspending any subject’s 
participation in the study in the event of any serious adverse event or any unexpected 
moderate adverse event. 
 
In this study, the Procedural Manual for Safety addresses the safety concerns listed 
above. 
 
Note that participants who report a history of suicide attempts, substance abuse, or other 
major psychiatric comorbidities will be screened out of the study, as is stated in the study 
criteria. 
 
A. Pre-Eligibility Screening Phone Interview  
 
1. Research participants in this study are deemed to be at mid- to high risk of harm. 
 
2. Potential Participants will be pre-screened over the telephone by a trained study 
coordinator to determine their eligibility to participate. No identifying information, hence 
no private health information, will be collected at this stage of recruitment, nor can any 
doctor-patient relationship be established. The pre-eligibility screening will occur during 
the recruitment process and prior to both enrollment and informed consent in order to 
eliminate participants with serious psychopathology that might require immediate 
psychiatric evaluation and treatment. The thoroughness of this pre-eligibility screening 
makes it unlikely that inappropriate participants will be enrolled. The study population 
will be selected to be mid- to high functioning with symptoms consistent with Major 
Depression Disorder (see protocol B, section C for inclusion/exclusion criteria). 
However, should a participant entered in the study later be determined to be in too much 
distress to participate, the study coordinators will speak with the participant and explain 
that the experimental treatments provided during the study may not be sufficient for their 
needs and will recommend that they speak with their primary care physician about 
seeking a mental health evaluation for treatment.  Potential participants will be advised of 
this possibility during the recruitment pre-eligibility screening call and for those who are 
enrolled, it will also be documented in the Informed Consent Form (ICF). 
 
2.a. Script for eligibility rejection (greater than the threshold for symptom severity or 
comorbidity exclusion) 
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Thank you for providing this information. Your answers indicate that the 
treatments we are testing may not be suitable for you. However, because of the 
symptoms you are having, I recommend you contact your primary care doctor 
and ask to be evaluated for possible depression. If you prefer or you don’t have a 
primary care doctor there’s a toll-free number for mental health treatment (800-
981-4357). If you call that number, they will help you to set up an evaluation by a 
mental health professional. Do you have any questions? 
 
3. The Pre-screening eligibility phone call interview will include administration of 
the PHQ-9, a measure that can detect the presence of depressive symptoms and assesses 
their severity.  Note: Participants in this phase will be only required to answer the first 8 
questions of the PHQ-9.  Questions regarding possible suicidal ideation, plans or attempts 
or thoughts about hurting themselves (i.e., Item 9 “Thoughts that you would be better off 
dead, or of hurting yourself” in the PHQ-9), will only be asked during the In-Person 
Intake session by the Study Coordinator. Such measure was determined by the study 
personnel in order to provide, if necessary, safety to the potential participants.     
 
 
B. 2) In-person Intake session (Safety plan was developed in coordination with the CRC 
Nursing)  
 
During the In-Person Eligibility screening, it is possible that the Study Coordinator will 
detect levels of distress or psychiatric symptoms indicating that participants need 
additional care beyond the treatment offered in the study.  Should this occur, the Study 
Coordinator will speak with the participant (who has been advised of this possibility 
during the eligibility phone call) and tell them that the level and/or nature of the distress 
they are reporting indicates that the treatment offered in the study would not likely be 
adequate for them and recommend that they speak with their primary care clinician and 
seek evaluation by a behavioral health specialist. The Study Coordinator will ask the 
participant to wait in the room while he/she contact responsible medical coverage in 
order to do the evaluation. Alternatively, they may choose to call the intake coordinator 
of their own health care network. 
 
We will exclude from participation individuals who endorse PHQ-9 item #9 (“Over the 
last two weeks, how often have you been bothered by …thoughts that you would be 
better off dead, or of hurting yourself in some way”) or endorse HSCL-20-d item # 14 
(“How much were you bothered by …thoughts of death or dying?) to screen for suicide 
risk.  
 
Participants who endorse Item #9 or #14 as “not at all” will be considered eligible but not 
those who endorse “several days”, “more than half the days” or “nearly every day” on the 
PHQ-9 or “a little bit, “Moderately”, “Quite a bit”, and “Extremely” on the HSCL-20-d. 
Thus, the score for item #9 and #14must equal = 0 (Zero).  Participants who score 1, 2, 3 
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on the PHQ-9 or 1- 4 on the HSCL-20-d will be excluded.  In such instances, the study 
coordinator will explain the reason for exclusion as described in section 3a or 3b. When 
the participant has indicated a score of 1 or higher on item #9 or #14, the study 
coordinator will use the following script: 
 
3a. Script for eligibility rejection (possible suicidal risk) 
  
Thank you for providing this information.  
 
Your answers indicate that the treatment we are offering in this study may not be 
suitable for you. However, because of the symptoms you are having, I am 
contacting the medical coverage right now, so you can be evaluated by one of 
them, please wait here in this room until help arrives. (A safety measure will be 
implemented according to the severity, risk and distress of the participants, see 
below). Also I will recommend you contact your primary care doctor as soon as 
possible. Because you checked off that you are having frequent thoughts you 
would be better off dead or of hurting yourself in some way, it’s important that 
you be evaluated for treatment. Depression is a highly treatable condition and 
you need help right away. It is important that you call your primary care doctor 
within the next 24 hours and explain that you need to be seen as soon as possible, 
but definitely within the next two days. If your doctor cannot see you that quickly, 
ask where can you be referred for an urgent evaluation. If they are closed due to 
a weekend or holiday, you should go to your community hospital’s emergency 
room. If you prefer, there’s a toll-free number for mental health treatment (800-
981-4357). If you call that number, they will help you set up an evaluation by a 
mental health professional and can make arrangements for you to be seen 
immediately. Do you have any questions? May I call you back in two days to 
check to be sure you’ve been able to find help? 
 
3.b Script for eligibility rejection (serious suicidal risk) 
 
In the event that during the In-Person Intake session suggests that the prospective subject 
is in great distress and in urgent need of emergency psychiatric care with a considerable 
risk of self-harm, the patient should wait in the designed room at the BIDMC-CRC 
facilities while the Study Coordinator contacts the study medical coverage.  
 
While participant is waiting the Study Coordinator will provide to participant the contact 
number for an emergency mental health crisis (800-981-4357) or 911 or refer to the 
nearest ED and assistance offered to facilitate a transfer of the person to a provider who 
can take responsibility for the person’s safety. Also a specific plan will be implemented.   
The study coordinator should stay in contact with the patient until care has been arranged, 
or until a family member, friend, or ambulance has agreed to bring the person to an ED 
for evaluation. 
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I’m very concerned about how much distress you are in. You need medical 
evaluation and treatment right away. (A safety measure will be implemented 
according to the severity, risk and distress of the participants at this time- see 
below). Can you call your primary care doctor and see if s/he can arrange for you 
to be seen right away? Can you call 911 or 800-981-4357? Is there someone who 
can bring you to your local hospital emergency room? Is there a mental health 
clinician who has treated you whom you could call right now? 
 
Suicide risk assessment 
 
Patients eligible for participation in the study are deemed to be suffering from depression 
and to be at middle to low risk for suicide based upon interview and structured self-report 
measures. To be enrolled, participants must not have reported more than occasional 
suicidal ideation and must have no history of suicide attempts or intentional self-injurious 
behavior.  
This will be determined by the following methods: 
The Patient Health Questionnaire 9 or PHQ-9 will be administered during the Enrollment 
Evaluation. Participants must endorse item 9, “Thoughts that you would be better off 
dead, or of hurting yourself” as 0 = “Not at all.” 
 
0 Not at all 
1 Several Days 
2 More than half the days 
3 Nearly every day 
 
The Hopkins Symptom Check List-20-d  (HSCL-20-d) will be administered during the 
following assessments: Baseline (week 0), Mid-point (week 4), Post-treatment (week 7), 
and Follow-up (week 14).  Participants must endorse item 14 “ thoughts of death or 
dying” as 0= “Not at all” to participate in the study.  
      0    Not at all 
      1    A little bit 
2    Moderately  
3    Quite a bit 
4 Extremely 
C. Evaluation During Treatment 
What if a patient’s depressive symptoms worsen during their participation in the study 
and s/he develops suicidal ideation or severe depression? 
Each week during the study, participants in the ePST group will complete the PHQ-9.  
During treatment and after follow-up, they will again complete the HSCL-20-d. DEC 
group will fill the measures at baseline, mid-point, post-treatment, and a 2-month follow-
up session.   
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During any of these sessions or time assessment points, if the participant indicates on the 
PHQ-9 or / and on the HSCL-20-d an increase to the score of 1 or greater on item 9 or 
item 14 (suicidal ideas) compared to the score on the previous visit, the Study 
Coordinator will contact immediately (i.e. within 10 minutes of observing the increased 
score) the psychiatric backup.  
 
Suicide Risk Protocol  
Severe Risk (ideation +, plan +, intent +, means +) 
1. If the patient is deemed to be at severe risk of suicide the Study Coordinator will: 1) 
immediately (i.e. within 10 minutes of observing the increased score) contact the 
psychiatric backup; 2) Call Security to assist in monitoring patient safety during care and 
transfer. In this situation participants will never be left unattended and Security must be 
present until a mental health specialist comes to assess the situation.  
3. The Study Coordinator will call the psychiatric backup and one of them will determine 
the situation and the course of action that must be taken.  
 
High Risk (ideation +, plan +, intent +) 
1. If the patient is deemed to be at high risk of suicide the Study Coordinator will: 1) 
immediately (i.e. within 10 minutes of observing the increased score) contact the 
psychiatric backup; 2) call Security to assist in monitoring patient safety during care and 
transfer. In this situation Patient will never be left unattended and Security must be 
present until a mental health specialist comes to assess the situation, and 3) The Study 
Coordinator will call the psychiatric backup and one of them will determine the situation 
and the course of action that must be taken  
 
Moderate Risk (ideation +, plan+, intent -) 
1. If participant’s assessment of suicide risk is moderate, the Study Coordinator will: 1) 
immediately (i.e. within 10 minutes of observing the increased score) contact the 
psychiatric backup; 2) The medical coverage then will assess the situation and they will 
determine the course of action that must be taken. 
Note:  If the participant has no health insurance, the participant will be instructed to 
contact his or her local community hospital or community health center to arrange a 
mental health evaluation. Participants will be instructed to call the study coordinator 
within 24 hours to confirm that they have followed through and to report the date of their 
appointment for a mental health evaluation. 3) The Study Coordinator will call the 
psychiatric backup and one of them will determine the situation and the course of action 
that must be taken. 
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 Appendix 6- Monitoring for Depression and Risk of Suicide protocol 
Step 1: Research Nurse confirm that the Participant ID on screen matches that on the  
 flashdrive tag. 
Step 2: Enter the Participant’s PIN number (found on the tag). 
 
 
 
Step 3: Participant completes the Depression Self-Assessment (called the PHQ-9). 
Step 4: Participant clicks CONTINUE button when done. 
Screenshot of the Depression Self-Assessment (PHQ-9) built into the software.  
 
CRC enters PIN here. Checks 
that matches the ID written on 
the flashdrive tag 
Participant clicks the Continue button 
when done answering assessment. 
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Step 5: Automated printout comes up. 
 
Step 6: CRC nurse reviews printout. NOTE that question 9 asks about suicidal ideation.  
 IF the Participant answers with a score of 1, 2, or 3 (on a 0 to 3 scale), Warning 
appears. (See printout example A). IF any Warnings appear, implement 
Procedural Protocol for Safety (Appendix 6). 
Example of an answered Depression Self-Assessment with a score of 2 in question 9. 
 
 
Indicates the level of depression 
Unique safety code number 
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Example of printout A.  
 
 
 
 IF the Participant scores in the Severe range of depression, Warning appears. 
(See printout example B). IF any Warnings appear, implement Procedural 
Protocol for Safety (Appendix 6). 
 
Example of a Depression Self-Assessment in the Severe range. 
 
 
Indicates the level of 
depression 
Message indicates suicidal 
ideation.  Implement procedural 
protocol for safety (Appendix 6). 
If the Q9 answer is greater than 
CERO, procedural protocol for 
safety is implemented. 
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Printout example B with warning message.  
 
 
 IF the Participant scores in the Mild range, and does not indicate suicidal 
ideation, no warnings appear (see printout example C). 
 
Printout example C  
 
This row indicates the level of 
depression. In this case 
procedural protocol for safety is 
implemented (see Appendix 7). 
Since the level is the mild range, there 
is NO need to implement procedural 
protocol for safety.  
If the Q9 answer is 3, procedural protocol 
for safety is implemented. 
Warning message 
indicating 
suicidal ideation. 
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Step 7: Enter the Continuation Code, from last line of the printout.  
Although the screen says “please notify your clinical assistant that you are ready to 
proceed, the safety code number will be only inserted by a Research Nurse if there is not 
suicidal risk.  
 
Step 8: Entering PIN number with the Safety code number. 
1. Continuation Code = first 3 digits of Participant Number + 3 digit “Code”  
NOTE: this screen was created to illustrate how both numbers are necessary to 
continue with the session.  
2. [Ignore Q10. It is not relevant to this study.]CRC or Study Coordinator Clicks the 
CONTINUE .  
button 
 
 
 
In this screen, the Continuation code would be 123775. 
CRC or CRC staff 
enters safety code 
number. 
In this case participants PIN 
number is 123 and the safety 
Code Number is 775.   
CRC nurse inserts 
the code 123775 
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Example of Continuation Code typed in. 
 
Step 9: the Research Nurse clicks CONTINUE button and authorize the participant 
continuing with his/her depression treatment session. 
Step 10: Research Nurse leaves the room.  
Step 11: Participants clicks CONTINUE button.  
 
Example of a full code 
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Step 12 Depression treatment session begins! 
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